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The research presented in this dissertation was conducted to further understanding of 
Ehrlichia spp. infections in dogs in the U.S. and Haiti. In chapter 3, to determine the risk 
of infection posed to dogs exposed to ticks in a natural setting, dogs were walked through 
tick habitat in northcentral Oklahoma and monitored clinically, serologically, and 
molecularly for four months for evidence of tick-borne infection. All 10 dogs were shown 
by serologic and molecular methods to be infected with E. ewingii, and 7 were co-
infected with E. chaffeensis; however, no dog exhibited clinical signs of ehrlichiosis. 
Four of these Ehrlichia spp. infected dogs were monitored for two years (Chapter 4) 
following tick-exposure to evaluate long-term Ehrlichia spp. infection. In this study, 
three of four dogs were infected with E. ewingii for at least 460 days while infection with 
E. chaffeensis was only detectable through day 55. These data demonstrate that dogs may 
serve as a reservoir host for maintaining E. ewingii. The third study (Chapter 5) was a 
pilot trial designed to evaluate the impact that previous infection with an Ehrlichia spp. 
has on reinfection through tick feeding and intravenous sub-inoculation. The Ehrlichia 
spp. infected dogs from Chapter 4 were exposed to ticks by walks and monitored for four 
months for evidence of reinfection with an Ehrlichia spp. as previously described in 
Chapter 3. No reinfections by tick feeding were detected; however, three dogs sub-
inoculated with E. ewingii and monitored for 46 additional days demonstrated molecular 
evidence of reinfection with E. ewingii. Lastly, Chapter 6 determined the prevalence of 
Ehrlichia spp. infections in 210 dogs from Haiti. Ticks infesting dogs were collected for 
identification and blood samples were evaluated by serologic and molecular methods for 
evidence of Ehrlichia spp. infections. Rhipicephalus sanguineus was the only tick 
collected from dogs. Ehrlichia canis was the only Ehrlichia spp. identified in these dogs; 
antibodies were present in 69 dogs and DNA was detected in 15 of those dogs. In 
summary, the risk of infection with an Ehrlichia spp. is high and infections may persist 
for years and alter future Ehrlichia spp. infections.
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Canine and human tick-borne ehrlichioses are increasingly common infections 
seen in the United States and throughout the world (McQuiston et al., 1999; Parola and 
Raoult, 2001; Ndip et al., 2005; Rani et al., 2011; Wu et al., 2013). Ehrlichia chaffeensis 
is the most common, potentially fatal tick-borne infection of people in the U.S., while E. 
ewingii is the most common Ehrlichia spp. detected in dogs (Little et al., 2010; Beall et 
al., 2012; CDC, 2014). Although difficult to track precisely, tick populations and the 
Ehrlichia spp. they transmit appear to be on the rise as well (Ogden et al., 2006; Gilbert, 
2010; Nicholson et al., 2010; Dahlgren et al., 2011; Adams et al., 2013; CDC, 2013; 
CDC, 2014). Based on existing survey data, dogs and people in the central U.S., 
particularly in Oklahoma, Arkansas, and Missouri, have an increased prevalence of 
Ehrlichia spp. infections compared to surrounding states, however many of these surveys 
lack a thorough patient history regarding travel as well as lifestyle of the person or pet 
which are important to consider when evaluating the risk for tick-borne infections in 
animals and people (Little et al., 2010; Dahlgren et al., 2011; Beall et al., 2012). 
Diagnosis of infection with Ehrlichia spp. can be a challenge (Ismail et al., 2010; 
Little, 2010; Harrus and Waner, 2011; Allison and Little, 2013). Detection of antibodies  
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is the most widely used diagnostic approach, although detectable antibodies may remain 
in circulation for years, even after treatment for Ehrlichia spp. infection, leading to 
clinical confusion regarding resolution of infection (Baneth et al., 1996; Bartsch and 
Greene, 1996; da Costa et al., 2005; Cardenas et al., 2007; Little et al., 2010). Molecular 
methods such as PCR are also utilized to detect DNA present during an active infection, 
but false negative PCR results may occur if inhib itors are present in the sample or if the 
DNA is not properly handled and stored (Beutler et al., 1990; Al-Soud and Radstrom, 
2001; Schrader et al., 2012). Isolation in cell culture and morulae visualization during 
examination of a cytologic preparation are also often employed in an effort to diagnose 
infection with Ehrlichia spp., but these diagnostic methods have their limitations as well, 
especially if the level of rickettsemia in the sample is low (Nyindo et al., 1971; Dawson 
et al., 1991; Wen et al., 1995; Popov et al., 1998; Chapman et al., 2006; Dumler et al., 
2007; Reeves et al., 2008). Incorporating the use of multiple diagnostic modalities in an 
infected dog or person should enhance accurate detection of infection with Ehrlichia spp.  
Although relatively common infections, there is much to be learned about the 
Ehrlichia spp. that infect dogs and people, especially regarding longevity of infection. 
Asymptomatic dogs have been shown to harbor E. chaffeensis and E. ewingii for months 
after experimental infection, and DNA of E. ewingii has been detected in naturally 
infected asymptomatic dogs (Breitschwerdt et al., 1998a; Liddell et al., 2003; Zhang et 
al., 2003; Yabsley et al., 2011). To date, no publications describe the persistence of 
infection with E. chaffeensis or E. ewingii in dogs when infection was acquired through 
natural tick exposure and feeding. Evaluation of dogs as a competent reservoir host for 
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Ehrlichia spp. would provide important information regarding how infected dogs should 
be managed to help prevent transmission of Ehrlichia spp. to naïve ticks. 
Prevention of infection to dogs and people with Ehrlichia spp. also warrants 
additional exploration. Currently there is no vaccine available to prevent infection with 
any of the canine or human Ehrlichia spp. Acaricide use and avoidance of ticks are the 
mainstays of preventing infection (Stafford, 2007; Cisak et al., 2012; Domingos et al., 
2013; CDC, 2014). Experimental studies with Ehrlichia spp. have shown that animals 
previously infected have fewer clinical signs or decreased bacterial loads when 
challenged subsequently with the same Ehrlichia spp. compared to cohort animals 
without previous infection (Buhles et al., 1974; Breitschwerdt et al., 1998b; Yabsley et 
al., 2011). Determination of the potential protection afforded subsequent to natural 
infection with different Ehrlichia spp. could provide insight into future vaccination 
prospects.  
To address these deficits in our understanding of canine ehrlichiosis, a series of 
experiments were undertaken: 
 
1) Determine the risk of infection to dogs posed by natural exposure to lone star 
ticks (Amblyomma americanum) and identify the Ehrlichia species involved. 
Infection with Ehrlichia spp. is common in dogs from the southeastern U.S., an 
area where Amblyomma americanum ticks are also commonly identified infesting dogs 
(Bowman et al., 2009; Beall et al., 2012; CDC, 2013; Barrett et al., 2014; Little et al., 
2014). Our study design mimicked how dogs become infested with ticks in a natural 
setting in order to determine the risk of infection with Ehrlichia spp. Dogs were walked 
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weekly for seven weeks to provide exposure to ticks in nature. During and after the tick-
exposure period, dogs were examined for presence of ticks and monitored clinically as 
well as by hematologic, serologic, and molecular methods to detect Ehrlichia spp. 
infections. Amblyomma americanum ticks were present on 10/10 dogs after every tick-
exposure opportunity and were the predominant tick (90.5%) seen infesting dogs (Barrett 
et al., 2014). Over the four-month study period, dogs developed antibodies reactive to E. 
chaffeensis (IFA: 10/10; VLPT: 7/10), E. ewingii (p28: 9/10), or both Ehrlichia spp. 
(VLPT + p28: 6/10). Detection of DNA of E. chaffeensis and E. ewingii were detected in 
7/10 and 10/10 dogs, respectively, yet no dog developed clinical signs indicative of a 
tick-borne infection. These data show that dogs have a high-risk—100% of dogs in this 
study— for acquiring an Ehrlichia spp. infection, especially in locations where A. 
americanum ticks are common. 
 
2) Characterize the persistence of infection with Ehrlichia chaffeensis and E. ewingii 
in dogs after natural tick exposure. 
Ehrlichia chaffeensis and E. ewingii infections have been detected in both 
experimentally and naturally infected dogs in the absence of clinical signs, and there is 
evidence to show that dogs can maintain active infection for months with either of these 
Ehrlichia spp. following experimental inoculation (Breitschwerdt et al., 1998a; Liddell et 
al., 2003; Zhang et al., 2003; Little et al., 2010; Yabsley et al., 2011). To evaluate the 
persistence of infection, dogs (n=4) from Study 1 were maintained in a tick-free 
environment for two years and monitored by serology and PCR for evidence of E. 
chaffeensis or E. ewingii infection. Dogs produced antibodies reactive to E. chaffeensis 
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(IFA: 4/4; VLPT: 2/4) and E. ewingii (p28: 4/4), with antibodies persisting in 3/4 dogs 
for the entire two-year study period. Detection of DNA was also observed in 4/4 dogs: E. 
chaffeensis in 2/4 and E. ewingii in 4/4. Ehrlichia chaffeensis DNA was not detected in 
any dog after day 55 while E. ewingii DNA was detected in 3/4 dogs through day 460 
with one dog remaining E. ewingii PCR-positive at the end of the two-year study. Our 
results provide evidence of long-term infection with E. ewingii in asymptomatic dogs 
with E. ewingii following natural tick-exposure.  
 
3) Conduct a pilot trial to evaluate the effect of previous natural infection with 
Ehrlichia chaffeensis or E. ewingii on challenge through tick feeding and 
intravenous inoculation.  
To date, there is no vaccine available for the prevention of Ehrlichia spp. 
infection. Studies have demonstrated that animals previously infected with an Ehrlichia 
spp. show less severe clinical signs and shorter durations of rickettsemia when later 
challenged with the same Ehrlichia spp. (Breitschwerdt et al., 1998b; Yabsley et al., 
2011). More recent work involving attempted peptide vaccinations in mice and dogs have 
shown that even though prevention of reinfection is not provided, disease is less severe 
and rickettsemia is more short-lived in the vaccinated animals (Croquet-Valdes et al., 
2011; Thomas et al., 2011; Rudoler et al., 2012).  
To determine if animals previously infected with E. chaffeensis or E. ewingii 
through natural tick feeding could be reinfected, the four dogs from Study 2 were re-
exposed to tick habitat weekly for seven weeks and monitored clinically, 
hematologically, serologically, and molecularly for four months for evidence of 
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reinfection with an Ehrlichia spp. None of the dogs developed clinical signs, hematologic 
abnormalities, or increases in antibody titer for four months following tick-exposure. 
Additionally, detection of E. chaffeensis or E. ewingii DNA was absent in 3/4 dogs; the 
only PCR-positive dog was E. ewingii PCR-positive prior to tick-exposure and remained 
positive throughout the four month period. The three dogs with no PCR evidence of 
Ehrlichia spp. infection following re-exposure to ticks were intravenously sub-inoculated 
with E. ewingii and monitored by the same methods for an additional 46 days. Clinical 
signs and hematologic abnormalities were absent in all dogs (3/3), however, a three-fold 
or more increase in antibody titer (E. chaffeensis IFA) was detected in 2/3 dogs and DNA 
of E. ewingii was detected in 3/3 dogs.  
Data from this study indicate that dogs may be protected from reinfection with 
Ehrlichia spp. if exposed by the same route of infection, tick feeding. Challenge by a 
different route of infection, intravenous sub-inoculation, did result in reinfection; 
however, durations of rickettsemia were brief and clinical signs were absent which is 
consistent with previously reported results (Yabsley et al., 2011). 
 
4) Determine the prevalence and identity of Ehrlichia spp. in dogs from Haiti, an 
area where lone star ticks are not present.  
Infection with Ehrlichia canis and other vector-borne pathogens has been 
identified in dogs from a number of Caribbean islands where Rhipicephalus sanguineus is 
the predominant tick, yet information regarding these infections in dogs from Haiti is 
lacking (Bool and Sutmoller; 1957; Huxsoll et al., 1970; Georges et al., 2008; L’Hostis et 
al., 1998; Yabsley et al., 2008; Asgarali et al., 2012; Kelly et al., 2013; Loftis et al., 2013; 
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Qurollo et al., 2014). To determine the species of ticks infesting dogs and the prevalence 
of vector-borne pathogens in dogs from Haiti, ticks and whole blood samples were 
collected from 210 dogs throughout Haiti. Ticks were detected on 28/210 dogs; all 
collected ticks were morphologically identified as Rhipicephalus sanguineus sensu lato. 
Whole blood revealed that approximately one-third (69/210) of dogs had antibodies 
reactivdee to E. canis or E. ewingii as detected by a commercially-available antibody 
assay. Furthermore, 15 of the antibody-positive dogs also had circulating DNA of E. 
canis. Many of the E. canis-positive dogs (39/210) had evidence of a co-infection with 
one or more vector-borne pathogens. Ehrlichia chaffeensis and E. ewingii were not 
detected in any dog from Haiti. Our results are the first to document the prevalence of R. 
sanguineus infestations and E. canis infections in dogs from Haiti.  
 
SUMMARY 
These studies provide information regarding the high-risk of infection with an 
Ehrlichia spp. in dogs in Oklahoma following natural tick-exposure, the ability of E. 
ewingii to persist long-term in dogs following a naturally acquired infection through tick 
feeding, the potential for a previous infection with an Ehrlichia spp. to protect against 
reinfection by the same Ehrlichia spp. through the same route of infection, and the 
prevalence of infestation with R. sanguineus and infection with E. canis and other vector-
borne pathogens in dogs from Haiti. Taken together, these data provide for a greater 
understanding of Ehrlichia spp. infections in dogs. First, the risk of infection to dogs in 
the absence of acaricide use is high. Furthermore, the diagnosis of Ehrlichia spp. 
infections in naturally infected, asymptomatic dogs provides insight into how long dogs 
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may remain infected with E. chaffeensis and E. ewingii following natural infection. 
Additionally, our data indicate that a previous Ehrlichia spp. infection in a dog may 
protect that dog against reinfection with the same Ehrlichia spp. through the same route 
of infection, thus providing helpful data to be used in future vaccine development. Lastly, 
our documentation of E. canis infections in dogs from Haiti along with reports of E. canis 
infections from other Caribbean islands suggests that animal and human health would 
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REVIEW OF LITERATURE 
 
EHRLICHIA SPP. OF PEOPLE AND DOGS 
 Members of the genus Ehrlichia are alpha-proteobacteria within the order 
Rickettsiales and the family Anaplasmataceae. Ehrlichia spp. are gram-negative staining 
intracellular coccobacilli that exist in either reticulate or dense-core cell forms (Rikihisa, 
1991; Dumler et al., 2001). Reticulate cells divide by binary fission. The dense-core cell 
is thought to be a dormant stage; however division has been observed, although to a 
lesser extent than what occurs with reticulate cells (Popov et al., 1995; Rar and 
Golovljova, 2011). The genome of Ehrlichia spp. ranges between 1.18 – 1.32 Mb and is 
contained on one circular chromosome (Dunning Hotopp et al., 2006; Mavromatis et al., 
2006). The genome of Ehrlichia spp., like many intracellular pathogens, is reduced 
compared to extracellular bacteria, and the majority of the retained genes typically code 
for vitamin, co-factor, nucleotide, and protein biosynthesis (Andersson and Kurland, 
1998; Dunning Hotopp et al., 2006; Rar and Golovljova, 2011). In the vertebrate host, the 
organisms replicate within intracytoplasmic parasitophorous vacuoles and are visualized 
as inclusions termed morulae. Replication site preference differs between the Ehrlichia 
spp., but occurs within leukocytes, including neutrophils, monocytes, and macrophages, 
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or within endothelial cells (Cowdry, 1925; Rikihisa, 1991; Popov et al., 1995; Dumler et 
al., 2001). Although direct transmission can occur through infected blood products, tick 
vectors are the primary means of transmission to vertebrates (Ewing, 1969; Groves et al., 
1975; Ristic and Huxsoll, 1984; Regan et al., 2013). Ehrlichia spp. are maintained 
transstadially and intrastadially in the tick host; there is no evidence of transovarial 
transmission as is seen with some other tick-borne disease agents (Groves et al., 1975; 
Anziani et al., 1990; Ewing et al., 1995; Johnson et al., 1998; Long et al., 2003; Bremer 
et al., 2005). However, infected vertebrate reservoirs are believed to maintain the 
organisms in the environment. 
Ehrlichia canis 
 Many Ehrlichia spp. are capable of infecting dogs which may lead to the 
development of clinical disease.  Ehrlichia canis, the agent responsible for canine 
monocytic ehrlichiosis, also known as tropical canine pancytopenia, was described in 
1935 as the first Ehrlichia spp. in a dog and was later detected in dogs from the United 
States as early as 1962 (Donatien and Lestoquard, 1935; Ewing and Buckner, 1965b). 
Clinical signs associated with E. canis infection in dogs include anorexia, lethargy, fever, 
epistaxis, and hemorrhages visible in the mucous membranes; severely affected dogs may 
die from this infection (Wilkins et al., 1967; Huxsoll et al., 1969, 1970a,b; Walker et al., 
1970; Huxsoll et al., 1972). Ehrlichia canis is transmitted between dogs by Rhipicephalus 
sanguineus ticks, but Dermacentor variabilis has also been shown to be a competent 
vector (Groves et al., 1975; Johnson et al., 1998). Rickettsial agents, including Ehrlichia 
sp., are transmitted more quickly, within 4 – 24 hours, when compared to other tick-borne 
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disease agents (Nicholson et al., 2010). Recent work described transmission of E. canis to 
dogs in as little as 3 hours after initiation of tick feeding (Fourie et al., 2013).   
Reservoir hosts for E. canis include domestic and wild canids (Ewing et al., 1964; 
Amyx and Huxsoll, 1973). Dogs surviving acute infection can circulate the agent for 
periods exceeding five years and serve as a source of infection to ticks (Ewing and 
Buckner, 1965a; Groves et al., 1975; Harrus et al., 1998). Ehrlichia canis is considered a 
low-risk zoonosis, but people have been shown to have antibody titers to E. canis, and 
there are case reports of clinical illness in humans from Venezuela that have 16S rRNA 
sequences matching sequences of E. canis obtained from local canines (Perez et al., 2006; 
Vieira et al., 2013). 
Ehrlichia chaffeensis 
 Perhaps the most important and pathogenic Ehrlichia spp. of humans to date is E. 
chaffeensis, the causative agent of human monocytic ehrlichiosis, which was first 
documented in people in 1986 (Maeda et al., 1987; Anderson et al., 1991; Paddock and 
Childs, 2003; Dahlgren et al., 2011). Not long after its description in people, E. 
chaffeensis was experimentally transmitted to dogs as well as detected in naturally 
infected dogs and wild canids (Dawson and Ewing, 1992; Dawson et al., 1996; Kocan et 
al., 2000; Zhang et al., 2003). Clinical abnormalities in dogs are milder than those 
associated with E. canis; signs range from inapparent illness to mild fever or 
thrombocytopenia (Dawson and Ewing, 1992; Zhang et al., 2003). A variety of other 
vertebrate species in the U.S., including cattle, goats, raccoons, lemurs, red fox, and 
white-tailed deer, have been reported to be naturally or experimentally susceptible to 
infection with E. chaffeensis with clinical illness ranging from imperceptible to death in 
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certain experimental studies (Davidson et al., 1999; Dugan et al., 2000; Williams et al., 
2002; de los Santos et al., 2007; de los Santos et al., 2008; Yabsley et al., 2008c). 
Humans often present with flu-like symptoms including fever, myalgia, headache, and 
joint pain; nausea and a rash are sometimes present as well (Anderson et al., 1991; 
Paddock and Childs, 2003). 
 The primary tick vector for E. chaffeensis is Amblyomma americanum, which has 
been experimentally shown to transmit E. chaffeensis to deer but not to dogs (Ewing et 
al., 1995; Long et al., 2003; Varela-Stokes, 2007). All life stages of this tick are found 
primarily on white-tailed deer but can be found on dogs, people, and other hosts in the 
southeastern U.S. (Bishopp and Trembley, 1945; Koch, 1982; Felz et al., 1996; Merten 
and Durden, 2000; Paddock and Yabsley, 2007). The geographical range of this tick is 
expanding to include areas along the east coast and into the upper Midwest (Keirans and 
Lacombe, 1998; Walker et al., 1998; Ijdo et al., 2000; Merten and Durden, 2000). Other 
potential vectors of E. chaffeensis include D. variabilis and R. sanguineus, as E. 
chaffeensis DNA has been detected in each of these tick species (Steiert and Gilfoy, 
2002; Ndip et al., 2007; Fritzen et al., 2011, Stoffel et al., 2014). White-tailed deer serve 
as the primary reservoir host for E. chaffeensis due to the vast number of PCR positive 
naturally infected animals identified in the southeastern U.S., their ability to transmit 
infection to naïve tick vectors, their lack of clinical illness and hematologic 
abnormalities, and their ability to remain rickettsemic and sequester bacteria in their 
lymph nodes and bone marrow long-term (Ewing et al., 1995; Little et al., 1997; 
Davidson et al., 2001; Arens et al., 2003; Yabsley et al., 2003a,b; Yabsley, 2010). Dogs 
may also serve as a natural host given their mild reaction to infection and the potential to 
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circulate E. chaffeensis for 2 – 4 months post infection (Dawson et al., 1996; Zhang et al., 
2003).  
Ehrlichia ewingii 
 Ehrlichia ewingii also infects dogs and people; however, neutrophils are the target 
vertebrate host cell. First thought to be a granulocytic form of E. canis, E. ewingii was 
later recognized in 1992 as a new agent of canine ehrlichiosis (Ewing et al., 1971; 
Anderson et al., 1992a). Disease in dogs varies from clinically absent to an acute febrile 
illness with lethargy and anorexia; lameness, joint effusion, and polyarthritis also can be 
seen during infection with E. ewingii (Cowell et al., 1988; Anderson et al., 1992a; 
Goodman et al., 2003, Yabsley et al., 2011). Dogs may also, albeit rarely, exhibit central 
nervous system signs and hemorrhage (Goldman et al., 1998; Goodman et al., 2003). 
People can also be infected with E. ewingii; clinical illness presents similar to that caused 
by E. chaffeensis with fever and flu-like symptoms (Buller et al., 1999; Salinas et al., 
2010). The primary tick vector for E. ewingii is also A. americanum (Anziani et al, 1990). 
Although DNA of E. ewingii has been detected in D. variabilis and R. sanguineus, 
experimental transmission by these ticks has not been confirmed (Steiert and Gilfoy, 
2002; Ndip et al., 2007; Lee et al., 2014). White-tailed deer are the proposed reservoir 
host, but dogs may play a role as well (Murphy et al., 1998; Steiert and Gilfoy, 2002; 
Yabsley et al., 2002; Liddell et al., 2003; Ndip et al., 2007). 
Panola Mountain Ehrlichia species 
 In 2006, a new Ehrlichia species was described in A. americanum ticks collected 
from Panola Mountain State Park, Georgia. Feeding of these ticks on a goat resulted in 
fever and mild clinical illness, however, the genetic sequence isolated from the infected 
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goat was genetically distinct from other Ehrlichia spp. found in the U.S. The sequence 
most closely resembled that of E. ruminantium, the causative agent of heartwater disease 
in ruminants outside of the U.S. (Loftis et al., 2006). To date, infection with the Panola 
Mountain Ehrlichia species (PME) has been reported in people, dogs, goats, and white-
tailed deer (Loftis et al., 2006; Loftis et al., 2008b; Reeves et al., 2008; Yabsley et al., 
2008a; Qurollo et al., 2013). Amblyomma americanum is the primary vector of PME 
which has been found in A. americanum ticks collected from 10 different states, 
including states in the northeastern U.S. where this tick has more recently been reported 
(Loftis et al., 2006; Loftis et al., 2008a; Schulze et al., 2011). Amblyomma maculatum, a 
competent vector for the related E. ruminantium, was shown experimentally to be capable 
of transmitting PME to a naïve goat (Mahan et al., 2000; Loftis et al., 2008b). White-
tailed deer are a likely wildlife reservoir host for the Panola Mountain Ehrlichia species 
(Yabsley et al., 2008a). 
Ehrlichia muris and E. muris-like Agent 
 The most recent Ehrlichia spp. to be described in dogs from the U.S. is E. muris 
(Hegarty et al., 2012). This agent was first described in 1995 in a mouse from Japan 
followed by a report in mice and humans from Russia (Wen et al., 1995; Nefedova et al., 
2008). A review of data collected from veterinary clinics in the U.S. from 2001 – 2007 
revealed that a higher than expected number of animals in Wisconsin and Minnesota had 
antibodies to an Ehrlichia spp. (Bowman et al., 2009). An earlier survey in Minnesota 
(2004 – 2005) had documented 11 of 731 naturally exposed pet dogs had Ehrlichia canis 
antibodies as detected by the SNAP® 4Dx® (Beall et al., 2008). Because these states are 
north of the historic geographic range of A. americanum, and R. sanguineus ticks are less 
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common in colder climates, infection with a novel Ehrlichia spp. was suspected (Bishopp 
and Trembley, 1945; Merten and Durden, 2000; Childs and Paddock, 2003). Molecular 
techniques detected E. muris DNA in a dog from Minnesota shortly after E. muris-like 
DNA was detected in people from the same region (Pritt et al., 2011; Hegarty et al., 
2012).  
 The E. muris infected dog exhibited a stiff gait with painful elbow joints, a fever, 
and decreased activity. Doxycycline therapy was instituted for three weeks, but the dog’s 
clinical signs recurred three months later. Additional laboratory diagnostics revealed mild 
thrombocytopenia and amplification of a sequence identical to that in a mouse from 
Japan (Hegarty et al., 2012). In people, disease due to the E. muris-like agent mimics that 
of the other Ehrlichia spp. infections, including fever, lethargy, headache, and 
thrombocytopenia (Pritt et al., 2011).  
Ixodes scapularis is the proposed vector of E. muris and the E. muris-like agent in 
the U.S. (Pritt et al., 2011; Hegarty et al., 2012). Ixodes scapularis ticks are prevalent in 
the upper Midwest while other known vectors of Ehrlichia spp. are scarce or absent 
(Schrock, 1982; Pritt et al., 2011). Evaluation of 760 I. scapularis collected from 
Wisconsin from 1992 – 1997 revealed that DNA of E. muris was present in 1% of ticks 
(Telford et al., 2011). Ehrlichia muris-like agent has also been detected in I. scapularis; 
co-infections of EML with the known I. scapularis transmitted pathogens Borrelia 
burgdorferi, Babesia microti, and Anaplasma phagocytophilum were detected in ticks 
collected from military personnel from Minnesota and Wisconsin (Stromdahl et al., 
2014). Additionally, the dog in the above case-report had antibodies to Anaplasma 
phagocytophilum, a rickettsial pathogen known to be vectored by I. scapularis, indicating 
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exposure of this dog to I. scapularis ticks (Pusterla et al., 2002; Hegarty et al., 2012). 
Reservoir hosts for E. muris and EML remain unknown. Recent work has shown DNA of 
EML in white-footed mice collected from Minnesota and Wisconsin; EML DNA was 
absent in white-tailed deer tested from Minnesota (Castillo et al., 2015).  
 
DIAGNOSTIC METHODS 
Blood Smear Evaluation 
 Definitive diagnosis of ehrlichiosis in people or animals can be difficult, and often 
a variety of diagnostic assays are used (Little, 2010; Allison and Little, 2013). A positive 
diagnosis can be achieved by direct microscopic visualization of morulae within the 
cytoplasm of an infected host cell on stained cytologic preparations, but the sensitivity is 
poor, especially if the patient is no longer in the acute stage of infection (Mylonakis et al., 
2004b; Chapman et al., 2006; Nicholson et al., 2010; Allison and Little, 2013). 
Sensitivity of direct microscopic visualization is influenced somewhat by the cell type 
infected and the sample type examined. For monocytic morulae (E. canis, E. chaffeensis, 
and E. muris), examination of peripheral blood smears is considered less sensitive than 
examination of buffy coat smears or lymph node aspirates (Mylonakis et al., 2003). 
Direct visualization of granulocytic morulae (E. ewingii) is often more readily achieved 
due, in part, to the relative number of neutrophils in circulation (Goodman et al., 2003; 
Allison and Little, 2013). Cytologic evaluation is also not specific for certain Ehrlichia 
spp., as the monocytic species (E. canis, E. chaffeensis, and E. muris) morphologically 
resemble one another (Wen et al., 1995; Popov et al., 1998); Ehrlichia ewingii is also 
morphologically indistinguishable from the related A. phagocytophilum, which also 
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forms morulae within the cytoplasm of granulocytes (Chapman et al., 2006). One benefit 
of cytologic evaluation is that it allows potential visualization of other blood related 
pathogens, as co-infections with vector-borne disease agents do occur in nature (Ewing 
and Buckner, 1965b; Breitschwerdt et al., 1998a; Kordick et al., 1999; Mylonakis et al., 
2004a; Gal et al., 2007; Yabsley et al., 2008b; Al Izzi et al., 2013).  
Cell Culture 
Another means of diagnosing infection with Ehrlichia spp. is to attempt to culture 
the organism in vitro, however, isolation of Ehrlichia spp. in cell culture is limited by the 
level of rickettsemia in the test sample as well as availability of viable cell lines in which 
the different Ehrlichia spp. can multiply (Nyindo et al., 1971; Dawson et al., 1991; Wen 
et al., 1995; Dumler et al., 2007; Reeves et al., 2008). This diagnostic approach has only 
been successful for the monocytic species, E. canis, E. chaffeensis, and E. muris (Nyindo 
et al., 1971; Dawson et al., 1991; Wen et al., 1995). There is one report in the literature of 
PCR amplification of E. ewingii from cell culture, however all attempts to isolate E. 
ewingii or Panola Mountain Ehrlichia sp. in continuous culture have failed thus far 
(Dumler et al., 2007; Reeves et al., 2008; Breitschwerdt et al., 2014).  
Serology 
 Serologic approaches are often utilized to identify antibodies reactive to Ehrlichia 
spp. Different methods have been developed, ranging in specificity from the cross-
reactive indirect fluorescence antibody (IFA) test to species-specific enzyme-linked 
immunosorbent assays (ELISA) (Ristic et al., 1972; Ohashi et al., 1998b; Sumner et al., 
1999; Cardenas et al., 2007; Daniluk et al., 2007; O’Connor et al., 2010). Some serologic 
diagnostic methods have been made available in patient-side assay format, while others 
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require the sample to be sent to a reference or a research laboratory for diagnosis 
(O’Connor et al., 2002; O’Connor et al., 2006; Abaxis Veterinary Reference 
Laboratories, 2015; Antech Diagnostics, 2015; IDEXX Laboratories, 2015). Cross-
reactivity between different Ehrlichia spp. is a major drawback when evaluating some 
serologic test results, as the antibodies developed to one species of Ehrlichia may cross-
react and bind to the antigen of a different Ehrlichia spp. in non-specific assays (Ohashi 
et al., 1998a; Waner et al., 2001). A serologic test may also fail to detect antibodies in the 
acute stage of infection before detectable levels are produced (Prince et al., 2007). A 
detectable antibody (IgG) response first develops by two to four weeks post-infection, but 
it has been shown that antibodies (IgG) can be detected in dog sera by E. canis IFA in as 
little as two days post-inoculation of E. canis infected macrophages (Iqbal et al., 1994; 
Cardenas et al., 2007). Another disadvantage of antibody-based tests is that they do not 
differentiate between current and previous infection, as antibodies are readily detected in 
clinically healthy persons and dogs (Baneth et al., 1996; da Costa et al., 2005; Little et al., 
2010). Persistently seropositive animals have been reported in the literature. Dogs were 
followed post-treatment for Ehrlichia spp. infection and 27 of 39 animals with an initial 
titer of 1:2,560 or greater remained seropositive for up to a year post-treatment (Bartsch 
and Greene, 1996). Additionally, 12 dogs were monitored post-treatment, and all dogs 
had a detectable Ehrlichia spp. titer at the last serologic evaluation 6 – 12 months 
following treatment (Breitschwerdt et al., 1998a). Chronic infection despite antibiotic 
therapy and reinfection are potential reasons for the persistent elevated titers as six of the 
12 dogs were PCR or tissue culture positive for Ehrlichia spp. following treatment 
(Breitschwerdt et al., 1998a; McClure et al., 2010).  
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Polymerase Chain Reaction 
 Molecular methods are also available for diagnosing ehrlichial infection. 
Polymerase chain reaction (PCR) assays, including nested and real-time, are sensitive and 
specific methods used to amplify circulating rickettsial DNA. Targets for Ehrlichia spp. 
PCR include ribosomal DNA (16S rDNA), disulfide bond formation protein gene (dsb), 
heat shock protein (GroESL), citrate synthase (gltA), and a variable length PCR target 
(VLPT) (Anderson et al., 1992b; Sumner et al., 1999; Felek et al., 2001; Inokuma et al., 
2001; Loftis et al., 2003; Bell and Patel, 2005; Doyle et al., 2005).  When utilizing proper 
positive and negative controls and in the absence of contamination, interpretation of a 
positive PCR is straightforward if specific primers were used; sequence confirmation can 
be performed on the amplicons to confirm accurate diagnosis (Anderson et al., 1992b; 
Iqbal et al., 1994; Allison and Little, 2013). Identification of an infection prior to 
antibody formation and differentiation between previous or current infection in a 
seropositive host are two advantages of DNA detection (Iqbal et al., 1994; Harrus and 
Waner, 2011). Another advantage is the capability of detecting multiple tick-borne 
pathogens through the utilization of multiplex PCR assays (Sirigireddy and Ganta, 2005; 
Kledmanee et al., 2009; Peleg et al., 2010; Rufino et al., 2013; Killmaster et al., 2014). 
Conversely, interpretation of a negative PCR result is more difficult and may indicate that 
there wasn’t sufficient amplifiable DNA present in the sample type collected, that 
inhibitors were present in the clinical sample rendering the assay falsely negative, or that 
the animal is truly negative (Beutler et al., 1990; Al-Soud and Radstrom, 2001; Schrader 






 The treatment of choice for ehrlichial infections is doxycycline at 10 mg/kg orally 
once a day for 28 days (Neer et al., 2002).  Other antibiotic options for the treatment of 
ehrlichiosis include rifampin, imidocarb, and other tetracyclines (Price and Dolan, 1980; 
Matthewman et al., 1994; Sainz et al., 2000; Schaefer et al., 2008). Improvement in 
clinical signs is usually seen within the first week after treatment has been initiated (Neer 
et al., 2002).  
Treatment Does Not Guarantee Clearance of Infection 
 Without treatment, dogs can maintain infection long-term with Ehrlichia canis 
and potentially other Ehrlichia spp. and serve as a potential source of infection; however, 
appropriate treatment with antibiotics does not ensure clearance of infection (Harrus et 
al., 1998; Zhang et al., 2003; Yabsley et al., 2011). Ehrlichia canis has been isolated from 
blood and tissues of dogs that were experimentally infected by intravenous inoculation or 
tick feeding and subsequently treated with doxycycline (Iqbal and Rikihisa, 1994; 
Schaefer et al., 2007). DNA of E. canis has also been detected in naturally infected dogs 
after treatment with doxycycline (Wen et al., 1997). Furthermore, nymphal and adult 
ticks fed on E. canis infected dogs post-treatment became infected, and molted adults 
were able to transmit E. canis to naïve dogs (Schaefer et al., 2007; McClure et al., 2010).  
Elimination of E. canis infection was seen, however, in dogs experimentally infected by 
intravenous inoculation after a 14 day regimen of doxycycline (Breitschwerdt et al., 
1998b). Route of infection, duration of antibiotic therapy, and stage of infection when 
treatment is implemented could all factor in to these conflicting data.  
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PREVALENCE OF EHRLICHIA SPP. INFECTIONS 
 The prevalence of Ehrlichia spp. infection in dogs, people, and ticks has been 
established in different states and regions of the U.S. and in some Caribbean islands. 
Prevalence is often determined in a host by using one or more of the previously discussed 
diagnostic methods. 
Prevalence in Dogs 
 Two large surveys testing more than 7 million dogs throughout the U.S. for the 
presence of antibody to Ehrlichia spp. were conducted from 2001 – 2007 and 2010 – 
2012 using a combination of patient-side ELISAs (SNAP® 3Dx®, 4Dx®, and 4Dx® 
Plus; IDEXX Laboratories, Inc., Westbrook, Maine) designed to detect antibodies to E. 
canis, E. chaffeensis, and E. ewingii (Bowman et al., 2009; Little et al., 2014). Dogs in 
the Southeast had the highest prevalence of Ehrlichia spp. antibodies (1.3% 
[3,865/290,636] – 3.2% [65,191/2,057,984]); regional Ehrlichia spp. antibody prevalence 
for the Northeast, Midwest, and West were 0.3% (777/271,070) – 0.9% 
(24,011/2,806,112), 0.4% (1,354/373,090) – 1.0% (17,337/1,720,168), and 0.6% 
(299/47,540) – 1.3% (5,134/410,419), respectively (Table 1). The state with the highest 
seroprevalence of Ehrlichia spp. antibodies from both surveys was Arkansas (Table 1). 
Two additional nationwide surveys testing over 15,000 dogs were conducted utilizing a 
species-specific peptide assay (SNAP® M-A, IDEXX Laboratories, Inc., Westbrook, 
Maine) for the detection of antibodies to E. canis, E. chaffeensis, and E. ewingii (Beall et 
al., 2012; Qurollo et al., 2014). Antibodies in dogs to E. ewingii were most common in 
both surveys (3.8% [251/6,582] – 5.1% [#439/8,662]) (Table 1).  
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 Presence of Ehrlichia spp. infections in dogs has also been explored in local or 
regional studies (Table 1); states with additional local data on Ehrlichia spp. antibody 
presence in dogs include Arizona, Arkansas, Connecticut, Louisiana, Missouri, New 
York, North Carolina, Oklahoma, Tennessee, and Virginia (Stephenson & Ristic, 1978; 
Hoskins et al., 1988; Rodgers et al., 1989; Stockham et al., 1992; Magnarelli & 
Anderson, 1993; Dawson et al., 1996; Murphy et al., 1998; Kordick et al., 1999; 
Suksawat et al., 2000; Liddell et al., 2003; Seaman et al., 2004; Diniz et al., 2010; Little 
et al., 2010). A number of studies have also evaluated the prevalence of canine infection 
with E. canis from different Caribbean islands where R. sanguineus is common; 
Ehrlichia spp. antibodies have been detected in 24.1% (41/170) – 47.6% (89/187) of dogs 
(Table 2) ( Georges et al., 2008; Hoff et al., 2008; Yabsley et al., 2008b; Asgarali et al., 
2012; Kelly et al., 2013; Loftis et al., 2013; Qurollo et al., 2014).  
 In addition to seroprevalence studies in dogs, several researchers have evaluated 
dogs by PCR assays from Arizona, Arkansas, Missouri, North Carolina, Ohio, Oklahoma, 
Tennessee, Virginia for the presence of circulating rickettsemia indicating active 
infection with Ehrlichia spp. (Table 3)(Dawson et al., 1996; Wen et al., 1997; Murphy et 
al., 1998; Kordick et al., 1999; Liddell et al., 2003; Seaman et al., 2004; Diniz et al., 
2010; Little et al., 2010). Infection with E. canis was most common in Arizona (36.5% 
[85/233]), whereas E. ewingii (12.2% [59/482]) and E. chaffeensis (5.4% [26/482]) were 
more commonly detected in dogs tested from the other states (Table 3). Dogs from three 
Caribbean islands, Grenada, St. Kitts, and Trinidad, have also been tested for presence of 
Ehrlichia spp. DNA (Georges et al., 2008; Yabsley et al., 2008b; Kelly et al., 2013; 
Loftis et al., 2013). Prevalence of E. canis infection was highest in dogs from Grenada 
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(24.7% [18/73]); overall prevalence of E. canis infection was 17.0% (163/958) in dogs 
from all three islands (Table 2).  
Prevalence in People 
 Since 1999, ehrlichiosis has been a reportable disease in the U.S. with data 
compiled annually; infection with E. chaffeensis accounts for the majority of the human 
cases, although infection with E. ewingii does occur (CDC, 2013). People in Oklahoma, 
Missouri, and Arkansas had the highest incidence rates (12.0, 11.4, and 10.3 cases per 
million persons per year, respectively) of E. chaffeensis reported from 2000 – 2007 in the 
U.S. (Dahlgren et al., 2011). In addition, recent reports document additional Ehrlichia 
spp. that infect people in the U.S., namely, Panola Mountain Ehrlichia sp. and an E. 
muris-like agent (Reeves et al., 2008; Pritt et al., 2011).   
Prevalence in Ticks 
 Ticks have also been surveyed for the presence of different ehrlichial agents that 
cause disease in animals and people (Table 4). Surveys report  E. chaffeensis in A. 
americanum from Arkansas, Connecticut, Georgia, Indiana, Iowa, Kentucky, Maryland, 
Missouri, New Jersey, New York, North Carolina, Oklahoma, Rhode Island, and 
Tennessee (Anderson et al., 1993; Lockhart et al., 1997; Burket et al., 1998; Roland et al., 
1998; Steiner et al., 1999; Ijdo et al., 2000; Irving et al., 2000; Whitlock et al., 2000; 
Steiert and Gilfoy, 2002; Mixson et al., 2004; Schulze et al., 2005; Mixson et al., 2006; 
Varela et al., 2004; Cohen et al., 2010; Fritzen et al., 2011; Blanton et al., 2014; 
Killmaster et al., 2014; Lee et al., 2014; Harmon et al., 2015). In E. chaffeensis endemic 
regions, prevalence of infection in adult A. americanum is typically between 5% and 15% 
(Childs and Paddock, 2003; Paddock and Yabsley, 2007). Dermacentor variabilis is also 
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suspected of transmitting E. chaffeensis; amplifiable DNA was present in 0% to 14.6% of 
unfed ticks collected from Arkansas, Kentucky, Missouri, North Carolina, and Tennessee 
(Roland et al., 1998; Steiert and Gilfoy, 2002; Cohen et al., 2010; Blanton et al., 2014, 
Lee et al., 2014). Ehrlichia chaffeensis DNA was not detected in any Ixodes scapularis 
tested from Connecticut, North Carolina, Rhode Island, and Tennessee (Ijdo et al., 2000; 
Cohen et al., 2010; Lee et al., 2014).  
 Ehrlichia ewingii has been reported in A. americanum ticks from Florida, 
Georgia, Kentucky, Missouri, New Jersey, New York, North Carolina, Tennessee, and 
Texas (Table 4) (Wolf et al., 2000; Steiert and Gilfoy, 2002; Long et al., 2004; Varela et 
al., 2004; Schulze et al., 2005; Mixson et al., 2006; Cohen et al., 2010; Fritzen et al., 
2011; Killmaster et al., 2014; Lee et al., 2014; Harmon et al., 2015). Additionally, DNA 
of E. ewingii has been detected in D. variabilis from Missouri and North Carolina (Steiert 
and Gilfoy, 2002; Lee et al., 2014). Evidence of E. ewingii was not present in I. 
scapularis from NC (Wolf et al., 2000; Lee et al., 2014). 
 Fewer studies have been conducted evaluating ticks for the presence of Panola 
Mountain Ehrlichia sp., E. muris, or E. muris-like agent (Table 4).  To date, DNA of 
Panola Mountain Ehrlichia sp. has been detected in A. americanum collected from 
vegetation or human hosts from Florida, Georgia, Kentucky, Maryland, Missouri, New 
Jersey, New York, North Carolina, Ohio, Oklahoma, and Tennessee (Loftis et al., 2008a; 
Fitak et al., 2014; Killmaster et al., 2014; Lee et al., 2014; Harmon et al., 2015). Ixodes 
scapularis from three states, Minnesota, Wisconsin, and Pennsylvania, have been tested 
for presence of E. muris or E. muris-like agent with positive ticks detected only in 
Minnesota and Wisconsin (Telford et al., 2011; Stromdahl et al., 2014). 
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Co-infections with Ehrlichia spp. 
 Co-infection with multiple tick-borne disease agents have been induced in 
experimental settings in dogs but are also seen in naturally infected people and dogs in 
the U.S. and in many other parts of the world (Klag et al., 1991; Breitschwerdt et al., 
1998a; Kordick et al., 1999; Suksawat et al., 2001; Mylonakis et al., 2004a; Beall et al., 
2008; Yabsley et al., 2008b; Nieto and Foley, 2009; Gaunt et al., 2010; Little et al., 2010; 
Beall et al., 2012; Al Izzi et al., 2013; Kelly et al., 2013; Loftis et al., 2013). Tick-borne 
agents frequently seen together in a co-infected person or dog are often transmitted by the 
same tick. For example, E. chaffeensis and E. ewingii are both vectored by A. 
americanum and are commonly seen in co-infected dogs (Anziani et al., 1990; Ewing et 
al., 1995; Breitschwerdt et al., 1998a; Little et al., 2010; Beall et al., 2012). Additionally, 
R. sanguineus, the most common vector for E. canis also transmits Hepatozoon canis and 
Babesia canis vogeli; dogs world-wide have been diagnosed with co-infections of these 
agents (Yabsley et al., 2008b; Kelly et al., 2013; Loftis et al., 2013; Rojas et al., 2014; 
Baneth et al., 2015). Evaluation of infectious agents in A. americanum from nine states 
concluded that 4.3% of the ticks had more than one infectious agent present (Mixson et 
al., 2004). Furthermore, E. muris along with A. phagocytophilum, Borrelia burgdorferi, 
or Babesia microti DNA was identified in ticks collected from Minnesota and Wisconsin 







PREVENTION OF EHRLICHIA SPP. INFECTION 
Vaccination 
 Prevention of Ehrlichia spp. infection is difficult. Vaccines for preventing 
ehrlichial infection in people or dogs have not yet been developed although some 
promising research has been reported (Maender and Tyring, 2004; Little, 2010; McBride 
and Walker, 2010; Rudoler et al., 2012; Thirumalapura et al., 2013). Many factors 
contribute to the difficulty in developing a vaccine against Ehrlichia spp. (McBride and 
Walker, 2010). First, each species of Ehrlichia displays genetic diversity among strains 
of the organism. The amino acid sequences of the 28-kDa outer membrane protein (p28) 
of different strains of E. chaffeensis vary by greater than 10% from one another, and 
immunization with the p28 protein of one strain may not provide protection against 
infection with different strains of E. chaffeensis (Yu et al., 1999). However, in mice 
challenged with E. muris, those vaccinated with certain p28 or Hsp60 peptides had lower 
bacterial loads after inoculation than unvaccinated mice, suggesting vaccination in this 
scenario may have provided partial protection (Crocquet-Valdes et al., 2011; Thomas et 
al., 2011).   
 Another obstacle is the number of different zoonotic Ehrlichia spp. present in the 
U.S. that a vaccine would be expected to prevent.  Ehrlichia chaffeensis, E. ewingii, and 
Panola Mountain Ehrlichia sp. have been shown to infect both dogs and people in the 
U.S. (Ewing et al., 1971; Maeda et al., 1987; Dawson et al., 1996; Buller et al., 1999; 
Reeves et al., 2008; Qurollo et al., 2013); E. muris and the closely related E. muris-like 
agent have been isolated from dogs and people, respectively, in the upper Midwestern 
states, while E. canis is seen in dogs worldwide, but reports of infection in people remain 
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isolated to South America (Ristic and Huxsoll, 1984; Perez et al., 2006; Pritt et al., 2011; 
Hegarty et al., 2012).  
 Development of an appropriate, yet feasible, animal model has also been a 
challenge facing vaccine development because the majority of Ehrlichia spp. that infect 
humans and dogs don’t sustainably infect mice (McBride and Walker, 2010). Recently, a 
model has been developed utilizing the E. muris-like agent in mice for use in vector-
transmission and immunity studies (Saito and Walker, 2015; Saito et al., 2015). An added 
challenge to vaccine development is the lack of an in vitro model for cultivation of the 
granulocytic Ehrlichia spp. (Dumler et al., 2007; Reeves et al., 2008). 
 Lastly, the nature of the pathogen itself poses a unique impediment to vaccine 
development as it has evolved to survive within the host cells and evade the immune 
mechanisms targeted towards clearance of intracellular bacteria (Mavromatis et al., 2006; 
Rikihisa, 2006; Nandi et al., 2009; Wakeel et al., 2010). 
Acquired Immunity 
 Even though vaccine development has not yet yielded a viable means of 
protection, it appears that acquired immunity may help clear an existing infection or 
lessen clinical signs with future infections. Experimental infection, treatment, and 
subsequent reinfection with two strains of E. canis showed decreased disease severity in 
the dogs reinfected with a homologous strain as compared to dogs given a heterologous 
strain post-treatment (Breitschwerdt et al., 1998b). These results could be due to potential 
virulence differences between the two strains of E. canis or to the primed immune system 
which may offer some protection regarding severity of a future infection. That same 
study showed that in the absence of antibiotics, four control animals were able to 
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eliminate or reduce infection to the point that it could no longer be detected by tissue 
culture isolation, PCR, or inoculation of blood into a naïve dog (Breitschwerdt et al., 
1998b). In dogs, previous infection with E. ewingii does not prevent experimental 
reinfection by blood sub-inoculation, but previously infected dogs became PCR negative 
for E. ewingii earlier than dogs without previous infection (Yabsley et al., 2011). These 
studies further support the potential for acquired immunity to lessen clinical signs or 
assist in clearance of infection.  
Limit Tick Exposure 
 The mainstay of preventing tick-borne infections, including human and canine 
ehrlichioses, is to limit contact with the tick. By limiting exposure to environments with 
ticks and thus reducing the number of ticks encountered, the chance of being fed upon 
and acquiring an infection decreases (Cisak et al., 2013; CDC, 2014). If absolute 
avoidance of tick habitat is not feasible, tick-control products and tick repellents should 
be used on pets and people, respectively (Nentwig, 2003; Stafford, 2007; Cisak et al., 
2013; CDC, 2014). Adult and juvenile stages of ticks are active at different times 
throughout the year in the U.S. spending the majority of their developmental time off-
host in an outdoor environment. Amblyomma americanum are often active spring through 
fall; adult activity peaks May – June, nymphs are active throughout summer, and the 
larval activity peaks in August (Goddard, 2007; Goddard and Varela-Stokes, 2009). 
Activity of the adults and nymphs of D. variabilis peaks May – July, while larval activity 
peaks both in September and again during the winter (Sonenshine, 1972; Kollars et al., 
2000). Ixodes scapularis activity differs in different regions: in the northeastern U. S., the 
activity of nymphs and larvae peaks from May – July, while adult activity peaks in 
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November and February (Platt et al., 1992; Kollars et al., 1999). Rhipicephalus 
sanguineus is unusual in that all life stages can be seen year round and this tick can 
survive indoors and develop under low relative humidity (35%) (Dantas-Torres, 2010).  
 Cumulatively, tick activity occurs during all months of the year, and transmission 
of Ehrlichia spp. can occur within hours of tick attachment thus highlighting the need for 
year-round implementation of an approved tick-control product on dogs (Stafford, 2007; 
Little, 2010; CAPC, 2014). Tick protection recommendations for people include wearing 
protective, light-colored clothing such as long pants taped to boots and a tucked-in long 
sleeve shirt (Stafford, 2007; Vazquez et al., 2008; CAPC, 2014; CDC, 2014). Light-
colored clothing allows better visualization of ticks and limits skin exposure, thereby 
limiting attachment sites.  Lastly, routine examination for ticks is recommended, 
especially after spending time in a potential tick environment (Stafford, 2007; CAPC, 
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0.3%  (1/337) 
7.5%  (3/40) 
-- 
-- 
1.5%  (5/337) 
0.0%  (0/40) 
-- 
-- 
3.6%  (12/337) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Alaska -- 0.0%  (0/2) 0.0%  (0/2) 0.0%  (0/2) -- Beall et al., 2012 













0.0%  (0/1) 





0.0%  (0/1) 





0.0%  (0/1) 









Diniz et al., 2010 
Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Stephenson & Ristic,    
    1978 











3.6%  (3/84) 
0.0%  (0/36) 
0.0%  (0/39) 
-- 
-- 
21.4%  (18/84) 
2.8%    (1/36) 




5.6%   (2/36) 






Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Little et al., 2010 









0.0%  (0/5) 
0.0%  (0/121) 
-- 
-- 
0.0%  (0/5) 
0.0%  (0/121) 
-- 
-- 
0.0%  (0/5) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 









0.0%  (0/5) 
3.7%  (9/246) 
-- 
-- 
0.0%  (0/5) 
0.0%  (0/246) 
-- 
-- 
0.0%  (0/5) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 





















0.0%  (0/97) 




0.0%  (0/97) 




0.0%  (0/97) 









Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Magnarelli  &  
    Anderson, 1993 










0.0%  (0/27) 
0.0%  (0/4) 
-- 
-- 
0.0%  (0/27) 
0.0%  (0/4) 
-- 
-- 
0.0%  (0/27) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 










0.5%  (4/733) 
2.6%  (13/501) 
-- 
-- 
1.2%  (9/733) 
2.2%  (11/501) 
-- 
-- 
2.6%  (19/733) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 










0.2%  (1/662) 
1.2%  (2/162) 
-- 
-- 
3.5%  (23/662) 
3.7%  (6/162) 
-- 
-- 
5.4%  (36/662) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Hawaii 7.0%  (166/2,359) 
-- 
-- 
0.0%  (0/2)  
-- 
0.0%  (0/2)  
-- 
0.0%  (0/2)  
-- 
-- 
Little et al., 2014 
Beall et al., 2012 













Bowman et al., 2009 
Little et al., 2014* 










0.0%  (0/489) 
0.3%  (1/383) 
-- 
-- 
1.8%  (9/489) 
0.5%  (2/383) 
-- 
-- 
1.6%  (8/489) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 










0.0%  (0/553) 
0.0%  (0/93) 
-- 
-- 
0.5%  (3/553) 
1.1%  (1/93) 
-- 
-- 
0.7%  (4/553) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 



















0.0%  (0/14) 
0.0%  (0/78) 
-- 
-- 
0.0%  (0/14) 
0.0%  (0/78) 
-- 
-- 
0.0%  (0/14) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 










0.9%  (4/457) 
1.9%  (1/53) 
-- 
-- 
1.1%  (5/457) 
1.9%  (1/53) 
-- 
-- 
6.8%  (31/457) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Kentucky 0.8%  (152/18,935)
a,b 






6.3%  (1/16) 
0.0%  (0/69) 
-- 
-- 
0.0%  (0/16) 
2.9%  (2/69) 
-- 
-- 
18.8%  (3/16) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 










1.5%  (4/274) 




0.0%  (0/274) 




0.7%  (2/274) 









Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Hoskins et al., 1988 











0.0%  (0/13) 
0.0%  (0/4) 
-- 
-- 
0.0%  (0/13) 
0.0%  (0/4) 
-- 
-- 
0.0%  (0/13) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 











0.8%  (2/254) 
1.0%  (3/313) 
-- 
-- 
3.5%  (9/254) 
8.0%  (25/313) 
-- 
-- 
3.5%  (9/254) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 













0.0%  (0/241) 
0.0%  (0/35) 
-- 
-- 
0.8%  (2/241) 
0.0%  (0/35) 
-- 
-- 
0.8%  (2/241) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 

















0.0%  (0/9) 
0.0%  (0/20) 
-- 
-- 
0.0%  (0/9) 
0.0%  (0/20) 
-- 
-- 
0.0%  (0/9) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 










0.0%  (0/7) 
12.5%  (1/8) 
-- 
-- 
0.0%  (0/7) 
0.0%  (0/8) 
-- 
-- 
0.0%  (0/7) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 










0.0%  (0/151) 
0.0%  (0/16) 
-- 
-- 
1.3%  (2/151) 
0.0%  (0/16) 
-- 
-- 
6.0%  (9/151) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 













0.8%  (5/663) 





12.8%  (85/663) 





22.8%  (151/663) 












Liddell et al., 2003 
Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Stockham et al., 1992 




0.0%  (0/1) 
-- 
0.0%  (0/1) 
-- 
0.0%  (0/1) 
-- 
-- 
Little et al., 2014* 
Beall et al., 2012 








1.6%    (1/62) 
33.3%  (1/3) 
-- 
0.0%  (0/62) 
0.0%  (0/3) 
-- 
0.0%  (0/62) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 





0.0%  (0/5) 
-- 
0.0%  (0/5) 
-- 
0.0%  (0/5) 
-- 
-- 
Little et al., 2014*  












0.0%  (0/28) 
0.0%  (0/19) 
-- 
-- 
0.0%  (0/28) 
0.0%  (0/19) 
-- 
-- 
0.0%  (0/28) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 



















0.4%  (1/257) 
0.0%  (0/12) 
-- 
-- 
1.9%  (5/257) 
0.0%  (0/12) 
-- 
-- 
2.7%  (7/257) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 











1.6%  (1/61) 
-- 
-- 
1.6%  (1/61) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 
Qurollo et al., 2014 










0.0%  (0/188) 




0.5%  (1/188) 




1.6%  (3/188) 








Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Magnarelli &     














0.7%  (3/403) 





5.7%  (23/403) 





5.2%    (21/403) 










Kordick et al., 1999 
Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 















Bowman et al., 2009 
Little et al., 2014* 









0.9%  (4/428) 
0.2%  (1/430) 
-- 
-- 
0.0%  (0/428) 
0.2%  (1/430) 
-- 
-- 
0.2%  (1/428) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 























1.8%  (9/514) 
2.4%  (1/42) 






1.0%  (5/514) 
0.0%  (0/42) 






7.2%    (37/514) 
14.3%  (6/42) 













Murphy et al., 1998 
 
Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 
Little et al., 2010 
Rodgers et al., 1989 








0.0%  (0/35) 
-- 
-- 
0.0%  (0/35) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 












0.0%  (0/96) 
0.5%  (1/203) 
-- 
-- 
0.0%  (0/96) 
0.5%  (1/203) 
-- 
-- 
1.0%  (1/96) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 


























Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 












8.8%  (3/34) 
0.0%  (0/93) 
-- 
-- 
8.8%  (3/34) 
7.5%  (7/93) 
-- 
-- 
5.9%  (2/34) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 










0.0%  (0/2) 
-- 
-- 
0.0%  (0/2) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 











2.8%  (5/181) 




2.8%  (5/181) 




7.7%  (14/181) 








Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 











     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 













2.0%  (18/893) 
3.1%  (30/966) 
-- 
-- 
0.1%  (1/893) 
0.5%  (5/966) 
-- 
-- 
0.6%  (5/893) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 








50.0%  (1/2) 
-- 
-- 
0.0%  (0/2) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 
Qurollo et al., 2014 








0.0%  (0/6) 
-- 
-- 
0.0%  (0/6) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 












0.5%  (2/385) 




6.5%  (25/385) 




8.1%  (31/385) 







Dawson et al., 1996 
Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 













0.0%  (0/12) 
-- 
-- 
0.0%  (0/12) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 












0.0%  (0/30) 
0.0%  (0/2) 
-- 
-- 
3.3%  (1/30) 
0.0%  (0/2) 
-- 
-- 
0.0%  (0/30) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 
Qurollo et al., 2014 









0.0%  (0/9) 
0.0%  (0/58) 
-- 
-- 
0.0%  (0/9) 
0.0%  (0/58) 
-- 
-- 
0.0%  (0/9) 





Bowman et al., 2009 
Little et al., 2014* 
Beall et al., 2012 





SNAP® 3Dx® ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  
b
SNAP® 4Dx® ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  
c
SNAP® M-A ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  
d
SNAP® 4Dx® Plus ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  
e
E. canis IFA 
f




















100.0%  (1/1) 
-- 
-- 
0.0%  (0/1) 
-- 
-- 




Bowman et al., 2009 
Little et al., 2014* 
Qurollo et al., 2014 
 
 
Table 2: Reported serologic and molecular prevalence of Ehrlichia spp. in dogs from the Caribbean 
 
Island Serology     Molecular  Citation 
 Ehrlichia spp.  
(p30/30-1)
a,b,c 









E. canis  
(IFA) 
E. canis  
(PCR) 
 
Grenada 42.9%  (76/177)
a,b
 -- -- -- -- 24.7%  (18/73) Yabsley et al., 2008b 













18.5%  (69/372) 
16.4%  (27/165) 
Kelly et al., 2013 












14.1%  (49/348) 
Asgarali et al., 2012 
Georges et al., 2008 
Turks & Caicos 47.6%  (89/187)
a
 -- -- -- -- -- Hoff et al., 2008 
Caribbean* 31.0%  (9/29)
c
 27.6% (8/29) 0.0% (0/29) 0.0% (0/29) -- -- Qurollo et al., 2014 
a
SNAP® 3Dx® ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  
b
SNAP® 4Dx® ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  
c
SNAP® M-A ELISA (IDEXX Laboratories Inc., Westbrook, Maine)  










Table 3: Reported molecular prevalence of Ehrlichia spp. in dogs from the U.S. as detected by 16S rRNA PCR 
 
State Ehrlichia spp. E. canis E. chaffeensis E. ewingii Citation 






Diniz et al., 2010
1,2
 






Little et al., 2010
1
 






Liddell et al., 2003
1
 






Kordick et al., 1999
1
 
Ohio -- 16.7%  (5/30)
 















1.2%  (3/255) 












3.9%  (10/255) 








Little et al., 2010
2 
Tennessee -- 0.0%  (0/90) -- -- Seaman et al., 2004
2
 








Dawson et al., 1996
1,2 
1
samples collected from pet dogs  
 
2






















Alabama  --        -- Aa: 0.0% (0/8)†‡
c
 -- Loftis et al., 2008a
2
 
Arkansas Aa: 1.2% (1/26*)†
d,e 
       0.0% (0/17*)‡
d,e
         





       -- 
       -- 
Dv: -- 
Aa: -- 
       --  
       0.0% (0/8)†‡
c 





Blanton et al., 2014
1 
 
Loftis et al., 2008a
2 
Blanton et al., 2014
1 
Connecticut Aa: 7.5% (8/106)†
a 
Is:   0.0% (0/50)†
a 
       -- 
       -- 
       --  
       -- 
-- 
-- 
Ijdo et al., 2000
2 
Delaware        --        -- Aa: 0.0% (0/12)†‡
c
 -- Loftis et al., 2008a
2
 
Florida Aa: 0.0% (0/151)†
e 
       --      
       -- 
Aa: 2.0% (3/151)†
g 
       -- 
       -- 
Aa: -- 
       0.7% (1/515)†
c 






Mixson et al., 2006
1 
Loftis et al., 2008a
1 
Loftis et al., 2008a
2 
Georgia Aa: 5.2% (13/250)†
a 
       0.0% (0/38*)‡
a 
       12.0% (6/50)†
a 
       3.5% (14/79*)†
a 
       1.7% (12/704)†
e 
       1.0% (4/398)†
a 
       2.0% (8/398)†
e 
       -- 
       -- 
       1.9% (23/1,183)†
a 




       -- 
       -- 
       -- 
       3.3% (23/704)†
g 
       4.8% (19/398)†
a 
       -- 
       -- 
       -- 
       2.1% (25/1,183)†
a 




       -- 
       -- 
       -- 
       --  
       -- 
       -- 
       0.9% (6/705)†
c 
       0.0% (0/343)†‡
c 
       1.4% (16/1,183)†
c 














Whitlock et al., 2000
1 
 
Lockhart et al., 1997
1 
 
Mixson et al., 2006
1 
Varela et al., 2004
1 
 
Loftis et al., 2008a
1 
Loftis et al., 2008a
2 
Killmaster et al., 2014
1 
Indiana Aa: 3.8% (10/55*)†
a 
       0.0% (0/32*)‡
a 
       -- 
       1.6% (15/184*)◊
a 
       4.9% (21/88*)†
a 
       0.0% (0/19*)‡
a 
       -- 
       -- 
       -- 
       -- 
       -- 
       -- 
Aa: -- 
       -- 
       0.0% (0/1)‡
c 
       -- 
       -- 







Irving et al., 2000
1 
 
Loftis et al., 2008a
2 
Steiner et al., 1999
1 








Iowa Aa: 5.3% (1/19)†
e
 Aa: 0.0% (0/19)†
g
        -- -- Mixson et al., 2006
1
 
Kansas Aa: 0.0% (0/3*)†
a 
       0.0% (0/5*)‡
a 





       -- 






Anderson et al., 1993
1 
 
Loftis et al., 2008a
2
 
Kentucky Aa: 5.6% (6/108)†
e    
       3.6% (1/7*)†
a
 
       0.0% (0/5*)‡
a
 
       0.0% (0/5*)†
a
 






       -- 
       -- 
       -- 





       -- 
       -- 
       -- 









Fritzen et al., 2011
2,3 
Anderson et al., 1993
1 
 
Anderson et al., 1993
2 
Loftis et al., 2008a
1 
Fritzen et al., 2011
2,3
 
Louisiana -- -- Aa: 0.0% (0/1)‡
c
 -- Loftis et al., 2008a
2
 
Maryland Aa: 3.5% (5/34*)†
a,e,f 
       0.8% (21/81*)‡
a,e,f 





       -- 






Stromdahl et al., 2000
1 
 











     1.9% (2/103)‡
b
 
Stromdahl et al., 2014
2 
 
Missouri Aa: 9.8% (57/579)†
a 
          
1.7% (8/115*)‡
a 
       28.8% (17/59)†
a 
       1.2% (1/9*)†
a
 
       0.0% (0/5*)‡
a
 
       -- 
Dv: 6.7% (8/120)†
a 





          
0.6% (3/115*)‡
a 
       -- 
       -- 
       -- 
       -- 
Dv: 3.3% (4/120)†
a 
       -- 
Aa: -- 
       -- 
       -- 
       --   
       -- 
      10.0% (1/10)†‡
c 
Dv: -- 









Steiert & Gilfoy, 2002
1 
 
Roland et al., 1998
1,2,3 
Anderson et al., 1993
1 
 
Loftis et al., 2008a
2
 
Steiert & Gilfoy, 2002
1 
Roland et al., 1998
1,2,3
 
Nebraska Aa: 0.0% (0/4)†
a 









Anderson et al., 1993
1 
Loftis et al., 2008a
2
 
New Jersey Aa: 12.4% (15/121)†
e
 
       -- 




       -- 
       -- 
Aa: -- 
      1.7% (2/120)†
c 






Schulze et al., 2005
1 
Loftis et al., 2008a
1 
Loftis et al., 2008a
2
 









New York Aa: 12.5% (59/473)†
e 
       1.4% (8/113*)‡
e 
       12.8% (61/475)†
e 
       -- 
       -- 
Aa: -- 
       -- 
      1.3% (6/475)†
g 
       -- 
       -- 
Aa: -- 
       -- 
       -- 
       0.8% (4/475)†
c 








Mixson et al., 2004
1 
 
Mixson et al., 2006
1 
Loftis et al., 2008a
1 







       0.0% (0/27*)‡
a
 
       1.0% (4/391)†
e 
       -- 
       -- 
       -- 
       -- 





       -- 
Is:   --  






       -- 
       5.9% (23/391)†
g 
       0.6% (3/462)†
a 
       0.4% (5/106*)‡
a 
       -- 
       -- 





       0.0% (0/1,349)◊
a 
Is:   0.0% (0/51)◊
a 






       -- 
       -- 
       -- 
       -- 
       0.0% (0/383)†
c 
       0.0% (0/93)†‡
c 
       0.4% (3/734)#
c 
Dv: -- 
       -- 
Is:   -- 















Anderson et al., 1993
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Mixson et al., 2006
1 
Wolf et al., 2000
1 
 
Loftis et al., 2008a
1 
Loftis et al., 2008a
2 
Lee et al., 2014
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Wolf et al., 2000
1 
 
Lee et al., 2014
2 
Ohio Aa: 0.0% (0/327)◊
c 










Fitak et al., 2014
1,2,,3
  
Loftis et al., 2008a
2 
Oklahoma Aa: 3.3% (2/60)†
e 
       -- 
Aa: 0.0% (0/60)†
g 
       -- 
Aa: -- 





Mixson et al., 2006
1 














Loftis et al., 2008a
2
 
Stromdahl et al., 2014
2
 
Rhode Island Aa: 11.5% (6/52)†
a 
       2.6% (1/38)†
e
 
       -- 
Is:   0.0% (0/63)†
a 
Aa: -- 
       0.0% (0/38)†
g 
       -- 
Is:   -- 
Aa: -- 
       -- 
       0.0% (0/1)†
c
 





Ijdo et al., 2000
1 
Mixson et al., 2006
1 
Loftis et al., 2008a
2 







       -- 
       -- 
Aa: 0.0% (0/79)†
g 
          
-- 
       -- 
Aa: -- 
      0.0% (0/80)†
c
   






Mixson et al., 2006
1 
Loftis et al., 2008a
1 









Tennessee Aa: 2.0% (8/396)†‡
b 
       2.6% (4/153)†
a
 











       0.9% (1/114)†
a 




       -- 
       -- 
Aa: 2.0% (8/396)†‡
c 
       -- 
       -- 
       -- 
       -- 







Harmon et al., 2015
1 
Cohen et al., 2010
1,2,3 
Texas Aa: 0.0% (0/66)†
a 
       -- 
       -- 
Aa: 7.6% (5/66)†
a 
       -- 
       -- 
Aa: -- 
       0.0% (0/44)†
c
   






Long et al., 2004
1 
Loftis et al., 2008a
1
  
Loftis et al., 2008a
2 
Virginia        --        -- Aa: 0.3% (1/368)‡
c
   -- Loftis et al., 2008a
2
 
Wisconsin        -- 
       -- 
       -- 
       -- 
       -- 
       -- 
       -- 
       -- 
       -- 
Is: 2.1% (2/96)†
b 
     0.0% (0/269)‡
b 
     0.9% (7/127*)†
a,b,c 
Stromdahl et al., 2014
2 
 
Telford et al., 2011
1 
Tick abbreviations: Aa (Amblyomma americanum), Dv (Dermacentor variabilis), Is (Ixodes scapularis), Am (Amblyomma maculatum) 
















*Pools (prevalence for pooled ticks is based on minimum infection rate [MIR] assuming only one infected tick per positive pool) 
1
ticks collected from vegetation  
2
ticks collected from humans 
3
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Starkey, L.A., Barrett, A.W., Chandrashekar, R., Stillman, B.A., Tyrrell, P., Thatcher, 
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 Dogs exposed to ticks in the southern US may become infected with multiple 
species of Ehrlichia. To better define infection risk, blood samples collected from 10 
dogs infested with ticks via a natural infestation model were evaluated by blood smear 
examination, PCR, patient-side ELISAs (SNAP® 4Dx® and SNAP® 4Dx® Plus), IFA, 
and peptide based ELISA for evidence of infection with Ehrlichia canis, E. chaffeensis, 
and/or E. ewingii. Although morulae were rarely identified in blood smears, every dog 
(10/10) became infected with Ehrlichia spp. as evidenced by nested PCR detection of E. 
chaffeensis (7/10) and E. ewingii DNA (10/10); real-time PCR detection of E. chaffeensis 
(0/10)  and E. ewingii (9/10); seroconversion on two different patient-side ELISAs (4/10 
or 10/10); seroconversion on IFA to E. canis (10/10, maximum inverse titer = 128 – 
4,096, GMTMAX=548.7) and E. chaffeensis (10/10, maximum inverse titer = 1,024 – 
32,768, GMTMAX= 4,096); and seroconversion on peptide specific ELISA to E. 
chaffeensis VLPT (7/10) and E. ewingii p28 (9/10). Rickettsemia with E. chaffeensis and 
E. ewingii, as determined by nested PCR, persisted in dogs for an average of 3.2 or 30.5 
days, respectively. Ehrlichia canis was not detected in any dog by any method, and no 
dogs developed signs of clinical disease. Our data suggest that in areas where ticks are 
common, dogs are at high risk of infection with Ehrlichia spp., particularly E. ewingii 
and E. chaffeensis, and can serve as a sentinel for monitoring for the presence of these 
zoonotic pathogens.  






 Dogs are known to be susceptible to infection with several different Ehrlichia 
spp. (Little, 2010). Ehrlichia canis, the causative agent of canine monocytic ehrlichiosis, 
is considered the most pathogenic; in some cases, fatalities result (Little, 2010). Ehrlichia 
ewingii has the capacity to set up long-term infections in dogs and may induce 
polyarthritis (Little, 2010). Other Ehrlichia spp., including E. chaffeensis, E. muris, and 
Panola Mountain Ehrlichia (PME), have also been reported from dogs (Little et al., 2010; 
Hegarty et al, 2012; Qurollo et al., 2013). A number of Ehrlichia spp. also have been 
reported to cause disease in humans, although E. chaffeensis is considered to be the most 
common and clinically severe (Nicholson et al., 2010). 
 Amblyomma americanum is responsible for transmission of E. chaffeensis, E. 
ewingii, and PME (Anziani et al., 1990; Ewing et al., 1995; Yabsley et al., 2008) in the 
southeastern US while Ixodes scapularis is the proposed vector for E. muris-like agents 
(Pritt et al., 2011; Hegarty et al., 2012). Infection with E. canis is most often seen only in 
dogs because the primary vector, Rhipicephalus sanguineus, prefers to feed on canine 
hosts (Dantas-Torres 2010). However, Dermacentor variabilis has also been shown to be 
capable of transmitting E. canis (Johnson et al., 1998). 
 Dogs in the southeastern United States have the highest seroprevalence for 
Ehrlichia spp. (Bowman et al., 2009; Beall et al., 2012). Infections are particularly 
common in areas where A. americanum populations are intense. All of the tick vectors 
mentioned are present in the southeastern US and may infest dogs in this region (Centers 
for Disease Control and Prevention, 2013). To determine the risk of ehrlichial infection to 
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dogs, we exposed dogs to tick habitat via weekly walks and evaluated them using 
clinical, serological, and molecular diagnostic techniques. 
 
MATERIALS AND METHODS 
Study Participants and Pre-screening 
 Oklahoma State University’s Institutional Animal Care and Use Committee 
reviewed and approved all animal protocols prior to the initiation of this study. Class A 
Beagle dogs (n=10), five months of age, were tested for evidence of current or previous 
infection with E. canis, E. chaffeensis, and E. ewingii by patient-side ELISA, indirect 
fluorescence antibody (IFA), species-specific peptide analysis, and nested and real-time 
polymerase chain reaction as described below prior to inclusion in the study. In addition, 
dogs were screened for infection with Anaplasma spp. and Borrelia burgdorferi (SNAP® 
4Dx®), as well as Rickettsia spp. (IFA) as previously described (Barrett et al., 2014). 
Tick Exposure and Clinical Monitoring for Disease 
 To ensure exposure to ticks, dogs were walked once per week for seven weeks in 
May and June, 2011, at a field station in Payne County, Oklahoma, as previously 
described (Barrett et al., 2014). Ticks acquired were allowed to feed to repletion. After 
the last walk, ticks were allowed to feed for one additional week and then all of the ticks 
were removed from each dog. Dogs were monitored daily over the entire exposure period 
in addition to two months following final tick exposure for clinical signs of infection, 






 Prior to tick exposure and twice weekly throughout the 121 day study, whole 
blood and serum were collected via jugular venipuncture as previously described (Barrett 
et al., 2014). Blood smears were made weekly.  Serum and whole blood were stored at  
–20°C until serology or PCR were performed. 
Serology 
 Antibodies to Ehrlichia spp. were detected using IFA tests as previously 
described (Ristic et al., 1972). Commercially available slides were used to test sera for 
antibodies reactive to E. chaffeensis and E. canis (Fuller Laboratories, Fullerton, 
California) with FITC-labeled goat-anti-dog IgG (KPL, Gaithersburg, Maryland) used to 
detect bound antibody. Every sample was screened at a 1/128 dilution; serial, two-fold 
dilutions of positive samples were evaluated until fluorescence was no longer observed, 
and the highest dilution at which specific fluorescence was observed reported as the 
maximum titer.  
 Species-specific peptide analysis was used to detect antibodies specific for 
Anaplasma spp. (eenz1), A. phagocytophilum (p44 aph), A. platys (p44 apl), Borrelia 
burgdorferi (C6), Ehrlichia spp. (p30/p30-1), E. canis (p16), E. chaffeensis (VLPT), and 
E. ewingii (p28) using a research SNAP prototype (Qurollo et al., 2014). Positive peptide 
values were quantified using a densigraph to determine the SNAP spot intensity 
(Chandrashekar et al., 2010). Commercially available patient-side enzyme linked 
immunosorbent assays (SNAP® 4Dx® and SNAP® 4Dx Plus®, IDEXX® Laboratories, 
Westbrook, Maine) were also employed for detection of antibodies to Ehrlichia spp., 
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Anaplasma spp., and B. burgdorferi. Serum was tested according to manufacturer’s 
instructions.  
Nested PCR and Sequencing 
 DNA was extracted from 200 µL of anticoagulated whole blood with the 
Illustra™ blood genomic Prep Mini Spin Kit (GE Healthcare UK Limited, 
Buckinghamshire, UK) according to manufacturer’s instructions from each dog on each 
collection date, and nucleic acid eluted into a final volume of 200 µL. Separate, dedicated 
laboratory areas were used for DNA extraction, primary amplification, secondary 
amplification, and product analyses, and negative (water) controls were included in each 
extraction and amplification. Species-specific 16S rDNA fragments were amplified by 
nested PCR using primers ECC/ECB followed by ECA/HE3 (E. canis), HE1/HE3 (E. 
chaffeensis), and EE72/HE3 (E. ewingii) as previously described (Little et al., 2010). 
Starting at study day 51 (d51) and working both toward d0 and d121, samples were tested 
until all 10 dogs were negative on two consecutive sample days (1 week). Standard 
agarose gel electrophoresis was used to confirm presence of amplicons, and 
representative amplicons purified and concentrated according to manufacturer’s 
instructions using a commercially available kit (Wizard PCR Preps, Promega 
Corporation, Madison, Wisconsin) were then submitted for sequencing at the Molecular 
Core Facility at Oklahoma State University (Stillwater, Oklahoma). Resultant sequences 
were compared to those available in the National Center for Biotechnology Information 






 To externally validate the nested PCR results, real-time Ehrlichia spp. PCR was 
performed at a separate facility using a different approach. Template DNA was extracted 
from 200 μL canine whole blood using  the High Pure PCR Template Preparation Kit 
(Roche Applied Science, Indianapolis, Indiana) according the manufacturer’s 
instructions. A final volume of 200 μL of eluted DNA was obtained for each sample. All 
sample DNA was stored at –20°C until testing. 
 Real-time PCR hybridization probe assays detecting the disulfide oxidoreductase 
gene of E. ewingii (DQ902688) and E. chaffeensis (AF403711) were used for the testing 
of the sample DNA. The real-time PCR assays were performed with the LightCycler 480 
instrument (Roche Applied Science, Indianapolis, Indiana). PCR was carried out in a 
total reaction volume of 20 μl containing LightCycler 480 Genotyping Master mix 
(Roche Applied Science), species specific primers and probes and 5 μl of template DNA 
(Ndip et al., 2007). Cycling parameters for the real-time PCR consisted of a denaturation 
cycle of 95°C for 10 minutes, followed by a 55 cycle amplification profile (95°C for 20 
seconds, 60°C for 30 seconds with a single data acquisition, 72°C for 20 seconds), a 
melting curve profile (95°C for 1 minute, 45°C for 1 minute and 80°C continuous with a 
ramp rate of 0.14°C per second and 4 data acquisitions per °C) and a cool cycle of 40°C 




 copies of recombinant plasmids containing an 
insert of the species specific target were tested as positive controls. PCR grade water 
(Roche Applied Science, Indianapolis, Indiana) was tested as the negative control. 




Complete Blood Counts and Blood Smears 
 Whole blood was submitted for complete blood count to the clinical pathology 
laboratory service, Oklahoma State University, from each dog on days 16, 44, 58, 72, and 
86. Thin blood smears were air dried, fixed in methanol, stained using Wright’s-Giemsa, 
and then examined microscopically for morulae within leukocytes by a boarded clinical 
pathologist (JHM).  
 
RESULTS 
 All dogs used in this study were seronegative for antibodies reactive to 
Anaplasma spp., Borrelia burgdorferi, and Ehrlichia spp. on all methods used, as well as 
PCR negative for Ehrlichia spp., prior to natural tick exposure.  As previously reported, 
dogs were infested with ticks on every exposure date for a total infestation of 57 – 108 
ticks per dog (Barrett et al., 2014).  The majority of ticks present were A. americanum, 
however low numbers of D. variabilis and A. maculatum were also seen.  Clinical signs 
of illness were never observed in any dog (Barrett et al., 2014). 
 All 10 dogs developed antibody titers on IFA to both E. canis and E. chaffeensis 
(Table 1).  Maximum inverse titers ranged from 128 – 4,096 for E. canis and 1,024 – 
32,768 for E. chaffeensis.  The geometric mean of the maximum inverse titers (GMTMAX) 
for E. canis and E. chaffeensis were 548.7 and 4,096, respectively (Figure 1).  
 Species-specific peptide analysis using the microtiter well based assays revealed 
antibodies to E. chaffeensis (VLPT) in 7/10 dogs, and E. ewingii (p28) in 9/10 dogs.  
Positive peptide values ranged from 0.03 – 0.45 for E. chaffeensis and 0.04 – 0.85 for E. 
ewingii (Figure 1).  Antibodies to E. canis (p16), B. burgdorferi (C6), or Anaplasma spp. 
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(eenz1, p44 aph, p44 apl) were not detected (Table 1).  On d121, 4/10 dogs had 
antibodies reactive to Ehrlichia spp. (p30/30-1) using the SNAP® 4Dx® patient-side 
ELISA, and 7/10 had antibodies reactive to Ehrlichia spp. (p30/30-1 and p28) using the 
SNAP® 4Dx® Plus (IDEXX Laboratories Inc., Westbrook, Maine). The three dogs 
which were negative on d121 on SNAP® 4Dx® Plus were positive on d61 or d93; in 
total, 10/10 dogs developed antibodies reactive to Ehrlichia spp. on SNAP® 4Dx® Plus 
during the study.   
 On nested PCR, 7/10 dogs tested positive on at least one study date for the 
presence of E. chaffeensis (Table 2a), 10/10 for E. ewingii (Table 2b), and 0/10 for E. 
canis (data not shown). Sequences from representative amplicons aligned with 100% 
identity to those for E. chaffeensis (NR_074500) or E. ewingii (NR_044747).  
Rickettsemia with E. chaffeensis and E. ewingii was detected intermittently in blood via 
nested PCR for an average of 3.2 and 30.5 total days, respectively. Real-time PCR 
detected E. chaffeensis DNA in 0/10 and E. ewingii DNA in 9/10 dogs throughout the 
study (Tables 2a and 2b). 
 As previously reported (Barrett et al., 2014), no significant changes were 
observed on any CBC.  A single morula was found in a neutrophil from one dog on d61 
and in two neutrophils from a second dog on d72. 
 
DISCUSSION 
 Diagnosis of tick-borne infections is increasingly common in the United States, 
both in animals and people (Nicholson et al., 2010). Our data reveal that the risk of 
infection is high even with a relatively limited time period of tick exposure. As evidenced 
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by PCR and serologic data, all dogs in this study became infected with Ehrlichia sp(p)., 
although infection with E. ewingii was more common than infection with E. chaffeensis. 
Some dogs remained PCR positive intermittently throughout the study, with 4/10 dogs 
still PCR positive for E. ewingii on d121, over two months after the final exposure to 
ticks, indicating persistent infection had been established. Previous work has shown that 
dogs can become persistently infected with E. ewingii following intravenous inoculation 
(Yabsley et al., 2011). The finding of persistent E. ewingii rickettsemia following natural 
tick exposure in the present study supports dogs as the proposed reservoir host for E. 
ewingii (Yabsley et al., 2011), although further study is needed to confirm that 
interpretation. 
 Results of the various diagnostic assays used in these dogs largely agreed with 
one another, although non-specific antibodies were detected on IFA before the specific 
peptide-based assays (Figure 1), and peptide-based assays may detect antibodies against 
Ehrlichia spp. that have not yet been described (Little, 2010). In addition, occasional 
discordant PCR results were observed which could be due to the different targets used, 
the relative sensitivity of the different assays, lower amounts of target present, or loss of 
detectable nucleic acid during storage of samples (Allison and Little, 2013). When 
considered together, the data from the present study support using multiple diagnostic 
modalities to identify infection, particularly early in infection when disease is most likely 
to develop (Little, 2010). However, identifying the most reliable testing modality for 
detecting early infection requires further exploration.  
Even though all dogs were shown to be infected with one or more Ehrlichia spp., 
none of the dogs exhibited clinical signs of illness, nor were there any blood work 
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abnormalities indicative of infection with an Ehrlichia spp. This observation mirrors what 
is commonly seen by practicing veterinarians: antibodies to one or more Ehrlichia spp. 
are commonly detected in dogs in which clinical disease is absent or inapparent (Little et 
al., 2010). Compared to E. canis, infection with E. chaffeensis is thought to be less 
pathogenic in dogs (Little, 2010), and disease from E. ewingii varies, with only a portion 
of infected dogs developing clinical illness (Anziani et al., 1990). Interestingly, the dogs 
in the present study were also infected with Rickettsia spp., albeit of unknown 
pathogenicity (Barrett et al., 2014). Despite this co-infection, disease was not evident. 
Previous work has shown co-infection with E. canis and A. platys does result in more 
severe clinical disease in dogs than either agent alone (Gaunt et al., 2010). Co-infection 
with multiple tick-borne disease agents has been reported in naturally infected dogs, 
although the influence of co-infection on disease severity is not always clear (Kordick et 
al., 1999; Little et al., 2010). 
Results from the present study show that dogs are a sensitive indicator for the 
presence of Ehrlichia infections in ticks; all ten dogs naturally exposed to ticks became 
infected with at least one Ehrlichia species in a single transmission season (Table 1). 
Canine seroprevalence studies have shown that antibodies to Ehrlichia spp. are most 
common in dogs from southeastern United States, with some areas identified where more 
than 10% of dogs test positive (Murphy et al., 1998; Bowman et al., 2009). In 
hyperendemic areas of Arkansas and Missouri, prevalence may be even higher; as many 
as 36.9% of dogs had antibodies to E. chaffeensis and 21.4% to E. ewingii (Beall et al., 
2012). Our data suggest that wide scale studies using canine serology may provide 
valuable insights into risk for human ehrlichiosis, similar to the success seen with this 
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approach in understanding the risk of other tick-borne disease agents, such as Borrelia 
burgdorferi (Duncan et al., 2005). 
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Table 1. Antibodies detected to Ehrlichia canis, E. chaffeensis, E. ewingii, Ehrlichia spp., Anaplasma platys,  
A. phagocytophilum, and Borrelia burgdorferi in 10 dogs naturally infested with ticks. 
  Organism 1° Tick Vector Analyte Months after initial tick infestation
a
 
   0 1 2 3 4 
  E. canis R. sanguineus IFA 0/10 1/10 8/10 8/10 8/10 
  E. chaffeensis A. americanum IFA 0/10 5/10 9/10 9/10 8/10 
  Ehrlichia spp. Various p30/p30-1 0/10 0/10 6/10 6/10 7/10 
  E. canis R. sanguineus p16 0/10 0/10 0/10 0/10 0/10 
  E. chaffeensis A. americanum VLPT 0/10 1/10 5/10 6/10 2/10 
  E. ewingii A. americanum p28 0/10 0/10 6/10 8/10 8/10 
  B. burgdorferi I. scapularis C6 0/10 0/10 0/10 0/10 0/10 
  Anaplasma spp. Various eenz1 0/10 0/10 0/10 0/10 0/10 
  A. phagocytophilum I. scapularis p44 aph 0/10 0/10 0/10 0/10 0/10 
  A. platys R. sanguineus p44 apl 0/10 0/10 0/10 0/10 0/10 
 
   a
Serum was tested by IFA on study days 30, 61, 93, and 121 and by ELISA using specific peptides on days 33,  
 














Table 2a. Detection by nested (and real-time) PCR of Ehrlichia chaffeensis in 10 dogs naturally infested with ticks. 
 
  Study Day Dog number         
 1 2 3 4 5 6 7 8 9 10 
  13 –  –  –  –  –  –  –  –  –  –  
  16 – (–) – (–) – (–) – (–) – (–) – (–) – (–) – (–) – (–) – (–) 
  19 –  – –  –  –  –  –  –  –  –  
  23 –  + –  –  –  –  –  –  –  –  
  26 –  – –  –  –  –  –  –  –  –  
  30 –  –  –  –  –  –  + –  –  –  
  33 – (–) – (–) – (–) – (–) – (–) – (–) + (–) – (–) – (–) – (–) 
  37 –  –  –  –  –  –  –  –  + – 
  40 –  + –  –  –  –  + + –  –  
  44 –  + –  –  –  –  –  –  –  –  
  47 –  + –  –  –  –  + –  –  + 
  51 – (–) + (–) – (–) – (–) – (–) – (–) + (–) – (–) – (–) – (–) 
  55 –  + –  –  –  –  –  –  –  –  
  59 –  –  –  –  –  –  –  –  –  –  
  61 –  –  –  –  + –  –  –  –  –  
  65 – (–) – (–) – (–) – (–) – (–) – (–) – (–) + (–) – (–) – (–) 
  67 –  –  –  + –  –  –  + –  –  
  72 –  –  –  –  –  –  –  –  –  –  
  75 –  –  –  –  –  –  –  –  –  –  
  Total
a
 0 16 0 1 1 0 8 3 1 2 
 
   a













Table 2b. Detection by nested (and real-time) PCR of Ehrlichia ewingii in 10 dogs naturally infested with ticks. 
 
  Study Day Dog number         
 1 2 3 4 5 6 7 8 9 10 
  30 – – – – – – – – – – 
  33 – (–) – (–) – (–) – (–) – (–) – (–) – (–) – (–) – (–) – (–) 
  37 – – – – – – – + – – 
  40 – – – – – – – + – – 
  44 – – – – – – – + – – 
  47 – – + – – – + + – – 
  51 – (–) + (+) + (+) – (–) – (–) – (–) + (–) + (+)    + (+) + (–) 
  55 + + + – – – + + + + 
  59 + + + – – + + + + + 
  61 + + + – + + – + + + 
  65 + (+) + (–) – (–) – (–) – (–) + (+) + (+) + (+) + (+) + (+) 
  67 + + – – – + – + + + 
  72 + – – + – + – + + + 
  75 + – – + – + – + – + 
  79 – (+) – (–) – (–) + (+) – (–) + (+) – (–) + (–) – (+) – (–) 
  82 – – – + – + – + – – 
  86 – – – + – + – + – – 
  89 – (–) – (–) – (–) + (+) – (–) + (+) – (–) + (+) – (–) – (+) 
  93 + – – – – + – – – – 
  96 – – – – – + – – – + 
  100 + – – – – + – – – + 
  103 + (+) + (+) – (–) – (–) – (–) + (–) + (+) – (+) – (–) + (+) 
  107 – + – – – + + + – + 
  110 – + – – – + + – – + 
  114 – + – – – + + – – + 
  117 – (–) + (+) – (–) – (–) – (–) + (–) + (+) – (+) – (–) + (+) 
  121 – + – – – + + – – + 
  Total
a
 23 34 14 17 1 62 31 53 21 49 
  
 a









Figure 1. Geometric mean titers to Ehrlichia chaffeensis and Ehrlichia canis on IFA (lines with standard errors) and arithmetic mean 
peptide values to Ehrlichia ewingii/p28 and Ehrlichia chaffeensis/VLPT (bars with standard errors) in dogs naturally infested with 
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Background: Ehrlichia ewingii, which causes disease in dogs and people, is the most 
common Ehrlichia spp. infecting dogs in the U.S. but little is known about how long E. 
ewingii infection persists in dogs. 
Hypothesis/Objectives: To evaluate the persistence of natural infection with Ehrlichia 
ewingii in dogs. 
Animals: Four Class A Beagles; no previous exposure to ticks or tick-borne infectious 
agents. 
Methods: Dogs were exposed to ticks by weekly walks through tick habitat in north 
central Oklahoma; dogs positive for infection with Ehrlichia spp. by sequence-confirmed 
PCR and peptide-specific serology were evaluated for 733 days (D).  Whole blood was 
collected once weekly for PCR, and serum was collected once monthly for detection of 
antibodies to E. canis (peptide p16), E. chaffeensis (IFA and VLPT), and E. ewingii 
(peptide p28). 
Results: All dogs (4/4) became infected with Ehrlichia spp. as evidenced by 
seroconversion on IFA to E. chaffeensis (4/4); PCR detection of E. ewingii (4/4) and E. 
chaffeensis (2/4) DNA using both nested and real-time assays; and presence of specific 
antibodies to E. ewingii (4/4) and E. chaffeensis (2/4). Infection with E. chaffeensis was 
not detected after D55. Intermittent E. ewingii rickettsemia persisted in 3 of 4 dogs for as 
long as 733 days. 
Conclusions and Clinical Importance: Our data demonstrate that dogs infected with E. 
ewingii from tick feeding are capable of maintaining infection with this pathogen long-




Keywords: Amblyomma americanum, granulocytic ehrlichiosis, reservoir host 
Abbreviations:  
PCR: polymerase chain reaction 
IFA: indirect fluorescence antibody test 
VLPT: variable-length PCR target 
GMTMAX: maximum geometric mean titer 
IgG: immunoglobulin G 
 
INTRODUCTION 
 Ehrlichia spp. are obligate intracellular bacteria transmitted by ticks that often 
infect white blood cells of mammals (Rar and Golovljova, 2011). A number of Ehrlichia 
spp. infections have been reported in dogs from the United States, including E. canis, E. 
chaffeensis, E. ewingii, Panola Mountain Ehrlichia sp., and E. muris (Little, 2010; 
Hegarty et al., 2012; Qurollo et al., 2013). Ehrlichia canis infection in dogs can cause 
anorexia, fever, epistaxis, hemorrhage, and sometimes results in death (Little, 2010; Rar 
and Golovljova, 2011). Ehrlichia ewingii also is an important pathogen in dogs. Fever, 
anorexia, thrombocytopenia, polyarthritis, and central nervous system abnormalities have 
been associated with E. ewingii infection in dogs (Little, 2010; Rar and Golovljova, 
2011). Although there is little data to support E. chaffeensis causing disease in dogs, this 
species as well as several other canine Ehrlichia spp. are known to cause disease in 
people (Little, 2010; Nicholson et al., 2010; Rar and Golovljova, 2011).   
 Ehrlichia ewingii is the most prevalent Ehrlichia spp. detected by serology in 




transmitted by Amblyomma americanum, the lone star tick (Little, 2010).  Infection with 
E. ewingii can cause clinically relevant disease in dogs, and dogs, in addition to white-
tailed deer, also may serve as a reservoir host for this agent (Little et al., 2010; Rar and 
Golovljova, 2011). Dogs are the primary reservoir host for E. canis, and infection can be 
maintained for several years (Little, 2010; Rar and Golovljova, 2011). There also is 
potential for dogs to serve as a reservoir host for E. chaffeensis, but their role appears to 
be less important than that of white-tailed deer (Little, 2010; Rar and Golovljova, 2011). 
To characterize the persistence of infection with E. ewingii in dogs after natural tick 
exposure, we evaluated 4 dogs for 2 years after initial tick exposure. 
 
MATERIALS AND METHODS 
Class A Beagle dogs (n=4) infected with E. ewingii and E. chaffeensis as 
previously described
 
(Starkey et al., 2014) were used for this study. All research was 
conducted under an Animal Care and Use Protocol approved by the Institutional Animal 
Care and Use Committee at Oklahoma State University. Briefly, dogs originally had been 
infested with ticks on 7 consecutive weekly walks and clinically monitored for evidence 
of tick-borne infection as previously described (Starkey et al., 2014). Whole blood was 
collected by jugular venipuncture twice weekly from study day (D) 0 through D121, and 
weekly from D256 – D733; serum was collected weekly from D0 – D121 and monthly 
from D256 – D712. Whole blood and serum were stored at –20°C until testing was 
performed. 
Antibodies to Ehrlichia spp. were detected using indirect fluorescence antibody 




commercially available E. chaffeensis IFA slides
a
 and fluorescein isothiocyanate (FITC)-
labeled goat-anti-dog IgG
b
 as previously described (Starkey et al., 2014). Sera also were 
analyzed for presence of antibodies against E. canis (p16), E. chaffeensis (VLPT), and E. 
ewingii (p28), with results measured by densigraph as previously described (Starkey et 
al., 2014).  
Nested polymerase chain reaction (PCR) assays were performed on DNA 
extracted from 200 µL of whole blood. To independently confirm the nested PCR results, 
real-time PCR also was performed on a subset of aliquots of samples collected every 2 
weeks from D0 – D121 and every other month from D256 – D712. DNA for nested PCR 
was extracted using a commercial kit
c
 according to the manufacturer’s instructions.  
Extraction of DNA for real-time PCR utilized the High Pure PCR Template Preparation 
Kit
d
 according to manufacturer’s instructions.  Extracted DNA was stored at –20°C until 
testing.  Nested PCR was employed to amplify species-specific 16S ribosomal DNA 
fragments using external primers ECC/ECB and internal primers ECA/HE3 (E. canis), 
HE1/HE3 (E. chaffeensis), and EE72/HE3 (E. ewingii) as previously described, with 
representative amplicons directly sequenced to confirm identity (Little et al., 2010). Real-
time PCR hybridization probe assays were used for detection of the disulfide 
oxidoreductase gene of E. chaffeensis (AF403711) and E. ewingii (DQ902688) as 









 All 4 dogs developed antibodies (inverse titers ≥ 128) on IFA to E. chaffeensis; 
antibodies were first detected by IFA as early as D26 and continued to be detected 
through the final day of the study in 3 dogs (Figure 1). Maximal inverse titers during the 
study ranged from 1,024 – 32,768. Near the end of the study, by D712, 2 dogs had titers 
≥ 4,096 (Figure 1). Specific antibodies to E. ewingii (p28) were absent at D33 for all 
dogs, detected in 3 dogs by D65, and detected in 1 dog by D89; E. ewingii specific 
antibodies persisted in all 4 dogs through D649 and in 3 dogs through D712. Maximal 
peptide values ranged from 0.25 – 1.08 as read by a densigraph (Figure 1). Specific 
antibodies to E. chaffeensis (VLPT) were absent at D33 but detected in 2 dogs by D65 
and persisted through D712 with maximal peptide values ranging from 0.18 – 0.45 
(Figure 1). Ehrlichia canis specific antibodies (p16) were not detected in any dog. 
 Two of 4 dogs had intermittently detectable E. chaffeensis DNA using the nested 
PCR assay on samples collected on D23 – D55 or D30 – D51, respectively, but E. 
chaffeensis DNA was not detected in any dog after D55. Real-time PCR did not detect E. 
chaffeensis DNA in any dog. All 4 dogs had detectable E. ewingii DNA by D59 using 
both PCR assays, with 2 dogs positive as early as D47 with nested PCR and by D51 with 
real-time PCR. One dog was PCR positive for E. ewingii only briefly (D47 – D61). 
Intermittent E. ewingii rickettsemia persisted long-term in 3 dogs. Two dogs were PCR 
positive D47 – D460 and the third dog was PCR positive D59 – D733.  Ehrlichia canis 
DNA was not detected by nested PCR in any dog. Development of clinical illness was 






 In the absence of transovarial transmission in ticks, maintenance of Ehrlichia spp. 
in nature requires persistently infected vertebrate hosts as reservoir hosts (Nicholson et 
al., 2010). The present study showed that some dogs maintain long-term infection with E. 
ewingii after limited exposure to ticks. Three of the 4 dogs we followed maintained 
infections for 15 months, with 1 dog remaining infected for >2 years. Infection in this 1 
dog continued until June 2014, more than 3 years after initial tick exposure (data not 
shown). Previous work has shown that infection with E. ewingii can be detected by PCR 
intermittently in dogs experimentally infected for at least 5 months after IV inoculation, 
and DNA also has been amplified from many apparently healthy client-owned or shelter 
dogs with unknown durations of rickettsemia (Little et al., 2010; Yabsley et al., 2011; 
Beall et al., 2012). Although many dogs die of serious disease, dogs have been shown to 
remain infected with E. canis for years while maintaining the ability to infect ticks, 
making them a key reservoir host (Little, 2010; Rar and Golovljova, 2011). The results of 
the present study suggest a similar situation may occur with E. ewingii in which dogs 
maintain long-term infections, potentially serving as a reservoir host, while also 
occasionally developing clinical disease associated with the infection. Breed as well as 
co-infection with multiple tick-borne agents may play a role in persistence of infection. 
However, results of this study are not consistent in that the 2 Ehrlichia spp. co-infected 
dogs maintained E. ewingii infection long-term (460 days) whereas the singly E. ewingii 
infected dogs maintained infection either briefly (up to 61 days) or long-term (>733 




 The persistence of E. ewingii infection in the dogs in the present study was 
documented by both serology and PCR. The inverse titers for the 3 persistently infected 
dogs exhibited small fluctuations throughout the 2-year study period, remaining within 3-
fold from the lowest measured titer (Figure 1). The species-specific average peptide 
values remained steady for E. ewingii (p28) throughout the study whereas the E. 
chaffeensis (VLPT) average peptide values showed an overall gradual decrease during 
the 2-year study period (Figure 1). Antibody titers to p28 remained stable in 2 dogs over 
8 months after the last positive PCR (D460) for E. ewingii, and detectable antibodies to 
VLPT still were present in 2 dogs 22 months after the last positive PCR for E. 
chaffeensis. The E. chaffeensis IFA utilized in this study detected antibodies in the sera of 
2 dogs consistently PCR-negative for E. chaffeensis, suggesting detection of cross-
reactive antibodies generated against E. ewingii. In the present study, infection with E. 
ewingii was detected in all 4 dogs by both nested and real-time PCR assays, whereas only 
nested PCR detected E. chaffeensis infection in 2 dogs. The reason for the occasional 
discordant results is not clear, but degradation of DNA could have occurred before 
sample processing and testing by real-time PCR assays (Allison and Little, 2013). 
Concurrent use of serologic and molecular diagnostic modalities likely would enhance 
detection of persistently infected animals.  
 Almost all of the known Ehrlichia spp. that infect dogs, including E. ewingii and 
E. chaffeensis, are zoonotic (Nicholson et al., 2010; Rar and Golovljova, 2011). Although 
most infections occur by tick feeding, transmission of Ehrlichia spp. also has been 
reported through contaminated blood products (Little, 2010). Dogs persistently infected 




and to veterinary staff members that may come into contact with infected blood (Little, 
2010). Persistently infected dogs also serve as a source of infection to ticks and may 
themselves acquire other tick-borne infections, which can lead to more severe disease 
(Little, 2010). The role that persistent infection with E. ewingii plays in the acquisition of 
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Figure 1. Inverse titers detected by IFA (lines; n=4) and species-specific mean peptide values to Ehrlichia ewingii/p28 and Ehrlichia 














































































PILOT TRIAL TO EVALUATE THE EFFECT OF PREVIOUS NATURAL 
INFECTION WITH EHRLICHIA CHAFFEENSIS OR E. EWINGII ON 











             




To evaluate the impact of a previous, naturally acquired ehrlichial infection on 
reinfection, we took four dogs with documented prior Ehrlichia chaffeensis or E. ewingii 
infections and walked them through tick habitat once a week for seven weeks. Ticks were 
identified and blood samples were collected for evaluation by blood smear examination, 
complete blood count (CBC), indirect fluorescence antibody (IFA) testing, and 
polymerase chain reaction (PCR) for evidence of reinfection with either Ehrlichia spp. 
Dogs became infested with 50 – 63 adult ticks over the entire infestation period (weekly 
average tick infestation = 8.4 ± 3.9); 91.9% of adult ticks were Amblyomma americanum. 
Antibodies to E. chaffeensis were detected by IFA (inverse titer >64; 512 – 8,192) in 3 of 
4 dogs on D0 and titers remained elevated (256 – 16,384), although largely unchanged, 
through D112; antibodies were not detected in one dog from D0 – D112. Nucleic acid of 
E. ewingii was detected in 1 of 4 dogs intermittently from D0 – D122. None of the other 
three dogs had detectable DNA of any Ehrlichia spp. throughout the study period, and no 
dog exhibited clinical signs or CBC abnormalities consistent with tick-borne infection. 
To determine if dogs were resistant to reinfection by other routes, the three dogs that 
were PCR negative for Ehrlichia spp. infection were sub-inoculated intravenously with 
whole blood containing E. ewingii from the single PCR-positive dog on D170 and 
monitored by blood smear, CBC, IFA, and PCR through D216. Again, no dog developed 
clinical signs or CBC abnormalities; however, all three sub-inoculated dogs became PCR 
positive for E. ewingii for 10 – 28 days following inoculation. Increases in inverse 
antibody titer were detected in two dogs, from <64 to 512 and 1024 to 8192, while the 
titers of the other two dogs remained largely unchanged. Our data suggest that although 
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dogs previously infected with Ehrlichia spp. remain susceptible to reinfection via IV sub-
inoculation, previous natural ehrlichial infections acquired from ticks may limit future 
infections through the same route. 
 
INTRODUCTION 
Tick-borne pathogens are present worldwide and cause disease in dogs and a 
variety of other hosts (McQuiston et al, 1999; Parola and Raoult, 2001; Nicholson et al., 
2010; Estrada-Peña and de la Fuente, 2014). Ehrlichia spp. are important and common 
tick-borne pathogens in the United States, particularly for people and dogs living in or 
traveling to the southeastern quadrant of the nation where E. chaffeensis and E. ewingii 
are endemic (Bowman et al., 2009; Beall et al., 2012; Little et al., 2014; Qurollo et al., 
2014).  
In the absence of a vaccine, the recommended approach for preventing tick-borne 
infections is to limit exposure to ticks and to use approved acaricidal products (Stafford, 
2007; Cisak et al., 2012; Domingos et al., 2013; CDC, 2014). However, it is evident that 
these methods of preventing infection are insufficient given that dogs and people in 
endemic areas continue to become infected with Ehrlichia spp. Surveys focusing on dogs 
from states in the southeastern U.S. have shown a high prevalence of Ehrlichia spp. 
infection, with Ehrlichia spp. antibodies reported in up to 96.3% of dogs and DNA of E. 
chaffeensis and E. ewingii detected in up to 33.3% and 29.6% of dogs, respectively 
(Dawson et al., 1996; Murphy et al., 1998; Kordick et al., 1999; Liddell et al., 2003; 
Little et al., 2010; CDC, 2014). Exploration into additional methods for preventing 
ehrlichial infections is warranted.  
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Previous work has shown that dogs develop less severe disease and shorter 
periods of rickettsemia upon reinfection with homologous strains of E. canis or E. 
ewingii (Breitschwerdt et al., 1998; Yabsley et al., 2011). Additionally, the use of an 
attenuated strain of E. canis as a vaccine was evaluated in dogs; following challenge with 
a wild virulent strain of E. canis by intravenous inoculation, clinical signs and rickettsial 
loads were decreased in the dogs that had received the attenuated strain of E. canis prior 
to challenge compared to the dogs that had not received the attenuated strain prior to 
challenge (Rudoler et al., 2012). In experimentally infected mice, those that received a 
specific peptide vaccination had lower bacteremia and less severe clinical signs upon 
challenge compared to non-vaccinated mice (Crocquet-Valdes et al., 2011; Thomas et al., 
2011). These studies suggest that while previously infected animals are not completely 
protected against reinfection, both clinical signs and rickettsemia are reduced. We used a 
natural tick feeding model and intravenous sub-inoculation to determine if natural canine 
infections with E. chaffeensis and E. ewingii resulted in a similar level of protection from 
reinfection.  
 
MATERIALS AND METHODS 
Study Participants and Pre-exposure Antibiotic Therapy 
Four class A Beagles (dogs 2, 3, 6, and 7) from a previous study that were 
infected with E. chaffeensis or E. ewingii following natural tick exposure (Starkey et al., 
2014) were utilized in the present study. Prior to initiation of the present study, all four 
dogs were monitored for presence of Ehrlichia spp. infection by serology and PCR for 
two years as described previously (Starkey et al., 2015). Infection was confirmed in each 
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dog at some point in the initial infection trial. Doxycycline hyclate (TEVA 
Pharmaceutical Industries Ltd., Tikva, Israel) was administered per os (10 mg/kg q 24 
hrs) for 28 days 5 months prior to reinfestation to two dogs (dogs 2 and 7) that had been 
confirmed to be PCR positive for both E. chaffeensis and E. ewingii. Dog 3 was only 
briefly PCR positive for E. ewingii and was not treated with antibiotics. Dog 6 was 
intermittently PCR positive for E. ewingii throughout the 2 year initial monitoring period 
and also was not treated.  
Tick Exposure and Intravenous Sub-inoculation 
To mimic a natural reinfection, dogs were walked through the same tall grass and 
wooded environment where ticks and Ehrlichia spp. infections had been acquired two 
years prior (Barrett et al., 2014; Starkey et al., 2014). Briefly, dogs were walked in pairs 
and rotated through 10 plots, spending 10 minutes in each plot (total walk time = 100 
minutes) for seven consecutive weeks from April to June, 2013. Between walks dogs 
were housed indoors to ensure no exposure to ticks other than those acquired from the 
walks for the entire 216 day study period. Whole body tick counts were performed after 
each walk as previously described (Little et al., 2007; Barrett et al., 2014); attached adult 
ticks were morphologically identified to species and allowed to feed to repletion (Keirans 
and Litwak, 1989). Following the natural infestation, dogs with no PCR evidence of 
Ehrlichia spp. infection were intravenously sub-inoculated on D170 with re-suspended 
buffy coat from an E. ewingii rickettsemic dog (dog 6) as previously described (Yabsley 
et al., 2011). Briefly, whole blood (35 mL) from dog 6 was aseptically collected via 
jugular venipuncture into EDTA collection tubes. Blood was immediately centrifuged at 
2500 x g for 10 minutes and the buffy coat layer and adjacent plasma and red blood cells 
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were aseptically recovered and re-suspended in filter sterilized 1X phosphate buffered 
saline (PBS). The total volume was divided equally into three parts (0.8 mL each) and 
inoculated intravenously into the left cephalic veins of dogs 2, 3, and 7.  
Clinical Monitoring and Sample Collection 
Dogs were monitored daily (D0 – D55 and D170 – D203) for clinical signs 
consistent with tick-borne infection (rectal temperature, lethargy, myalgia, ocular 
discharge, scleral injection, or conjunctivitis). Prior to tick re-exposure and throughout 
the first four months (D0 – D122) and last two months (D170 – D216) of the study, 
whole blood (EDTA) was collected twice weekly (D0 – D122 and D170 – D216) and 
serum was collected weekly (D0 – D112 and D170 – D212). Whole blood and serum 
samples were stored at –20°C until serology or PCR were performed. 
Serology 
Antibodies were detected by indirect fluorescence antibody (IFA) testing as 
previously described (Ristic et al., 1972). Commercially available slides (Fuller 
Laboratories, Fullerton, California) were used for IFA testing to detect antibodies 
reactive to E. chaffeensis through the use of FITC-labeled goat-anti-dog IgG (KPL, 
Gaithersburg, Maryland) as previously described (Ristic et al., 1972). Samples were 
screened at a 1/64 dilution; end-point titers were determined through sequential 
evaluation of two-fold serial dilutions.  
PCR 
Nested PCR for detection of Ehrlichia spp. DNA was performed as previously 
described (Little et al., 2010; Starkey et al., 2014). Briefly, DNA was extracted from 
whole blood according to manufacturer’s instructions using the Illustra™ blood genomic 
128 
 
Prep Mini Spin Kit (GE Healthcare UK Limited, Buckinghamshire, UK); amplification 
of 16S rDNA fragments was achieved through the use of Ehrlichia spp. external primers 
(ECC/ECB) followed by internal species-specific primers (E. canis: ECA/HE3; E. 
chaffeensis: HE1/HE3; E. ewingii: EE72/HE3). Amplicons were visualized using 
standard agarose gel electrophoresis with ethidium bromide.  
To confirm negative results from the natural re-exposure period, real-time PCR 
was performed as previously described (Starkey et al., 2014). Briefly, DNA was extracted 
from whole blood according to manufacturer’s instructions using the High Pure PCR 
Template Preparation Kit (Roche Applied Science, Indianapolis, Indiana); the disulfide 
oxidoreductase genes of E. chaffeensis (AF403711) and E. ewingii (DQ902688) were 
detected through the use of real-time PCR hybridization probe assays. 
CBC and Blood Smear Evaluation 
Whole blood was submitted from each dog for complete blood count and routine 
adjunct blood smear examination (IDEXX Laboratories, Inc., Westbrook, ME) on days   
–25, 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70 and to the clinical pathology laboratory 
service at Oklahoma State University on days 170, 177, 184, 191, and 198.  
Statistical Analysis 
 A Mann-Whitney rank sum test with significance assigned at P < 0.05 was 
employed to compare the total number of ticks acquired by dogs in the current study to 







Infestation with ticks was observed in every dog on each walking day (Table 1). 
The total number of ticks observed on each dog ranged between 58 and 71 (Table 1). 
Adult ticks present were either A. americanum (217 total) or D. variabilis (19 total); 28 
nymphs were also observed (species not confirmed). Three of four dogs were 
seropositive to Ehrlichia spp. by IFA before tick re-exposure. Initial inverse titers of 
positive dogs on D0 ranged between 512 and 8192 (Figure 1). Only a slight increase or 
decrease in monthly titer was observed in any dog following tick re-exposure (D0 – 
D112), including dog 3, which had no detectable titer throughout the reinfestation period 
(Figure 1). In three dogs, DNA of E. chaffeensis or E. ewingii was not detected by either 
nested or real-time PCR between D0 – D122 (Table 2). Dog 6 was PCR positive for E. 
ewingii on D0 and remained intermittently positive through D122 as detected by both 
nested and real-time PCR assays (Table 2).  
Following IV sub-inoculation, the inverse titer for dog 2 remained largely 
unchanged from D170 – D212. The inverse titer for dog 7 and 3 increased from 1,024 to 
8,192 from D184 – D205, and from less than 64 to 512 from D184 – D198, respectively 
(Figure 2).  Infection with E. ewingii was confirmed in all three recipient dogs (dogs 2, 3, 
and 7) as well as the donor dog (dog 6) by nested PCR following IV sub-inoculation 
(Table 2). Dog 2 was rickettsemic from D184 – D205, dog 3 from D181 – D209, dog 7 
from D181 – D191, and dog 6 on all test dates from D170 – D216 (Table 2).  
Clinical signs, significant changes on CBC, or morulae on blood smear were not 
observed in any dog following tick re-exposure or IV sub-inoculation.  
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The amount of ticks on dogs in the current study (median = 67.5 ticks) was not 
significantly different from the amount of ticks on dogs (median = 83 ticks) when initial 
Ehrlichia spp. infections were established (Mann-Whitney U= 2; df = 6; p = 0.11). 
 
DISCUSSION 
This study is the first to evaluate Ehrlichia spp. reinfection in dogs that were 
naturally infected with Ehrlichia spp. by tick feeding. Our results show that following re-
exposure to ticks, no dog developed serologic or molecular evidence of reinfection with 
either E. chaffeensis or E. ewingii, suggesting immunologic protection from reinfection 
may have occurred. However, because dogs were exposed in different years, and because 
negative controls were not walked at the same time as our previously infected dogs, 
adequate infection may have simply failed to establish.  
In comparing the two exposure periods, many variables were consistent including 
time spent walking through tick habitat, location of tick habitat, time of year, feeding 
time for ticks (to repletion), and methods used for monitoring both clinical illness and 
infection. However, some variables differed including average temperature, humidity, 
and fewer ticks detected on the dogs in the present study. Indeed, lower average daily 
temperatures in combination with higher humidity and rainfall could have impacted tick 
questing behavior and thus infestations between the two years (Mesonet, 2015; data not 
shown).  
The average prevalence of infection in ticks may also have differed between the 
two exposure periods. Unfortunately the prevalence of infection in adult A. americanum 
was not determined in 2011, but in 2013, 5/155 (3.2%) A. americanum collected from the 
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walking site had DNA of E. ewingii while none contained DNA of E. chaffeensis (data 
not shown). Additionally, one tick tested positive for DNA of Panola Mountain Ehrlichia 
sp. (PME). This is the first report of PME in questing ticks in Oklahoma although one 
previous report documented PME in a tick collected from a human in the state (Loftis et 
al., 2008).  
Interestingly, upon E. ewingii sub-inoculation, all three inoculated dogs developed 
detectable rickettsemia albeit in the absence of clinical signs. The two dogs with 
detectable antibody titers at day of inoculation (D170) had a shorter durations of 
rickettsemia compared to the dog with no initial titer, although level of titer did not 
appear to correspond to duration of rickettsemia (Table 2; Figure 2). Two dogs also 
exhibited an increase in antibody titer following reinfection (Figure 2). The results in the 
present study are similar to those reported from a previous study evaluating IV challenge 
in dogs previously infected with E. ewingii that showed previously infected dogs became 
rickettsemic for a similar period of time but did not have clinical signs (Yabsley et al., 
2011).  
Previous work has shown that up to 39% of dogs in Oklahoma have evidence of 
past or current infection with Ehrlichia spp. (Murphy et al., 1998; Little et al., 2010; 
Beall et al., 2012; Little et al., 2014; Qurollo et al., 2014). In the absence of tick 
prevention, the risk of infection to dogs with an Ehrlichia spp. can be high; a recent study 
determined that all (10/10) dogs exposed to tick habitat acquired infection (Starkey et al., 
2014). The data from the present study suggest that further research is needed to clarify 
the role that the components of the immune system play during Ehrlichia spp. infection 
132 
 
and reinfection, and that novel methods to prevent tick-borne infection would be a 
welcome addition to an integrated tick-control program.  
 
ACKNOWLEDGEMENTS 
Many thanks to Jeff Gruntmeir for technical laboratory support, technical staff at 
IDEXX Laboratories, Inc. for assistance with hematologic and molecular testing, 
technical staff at the Oklahoma State University clinical pathology laboratory service for 
assistance with hematologic testing, and laboratory animal resources at Oklahoma State 
University for support and care of the animals involved in this study. Funding to support 





Barrett, A, Little, S.E., Shaw, E., 2014. “Rickettsia amblyommii” and R. montanensis 
infection in dogs following natural exposure to ticks. Vector Borne and Zoonotic 
Diseases 14(1):20-25. 
Beall, M.J., Alleman, A.R., Breitschwerdt, E.B., Cohn, L.A., Couto, C.G., Dryden, 
M.W., Guptill, L.C., Iazbik, C., Kania, S.A., Lathan, P., Little, S.E., Roy, A., Sayler, 
K.A., Stillman, B.A., Welles, E.G., Wolfson, W., Yabsley, M.J., 2012. 
Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis, and Ehrlichia ewingii in 
dogs in North America. Parasites & Vectors 5:29. 
Bowman, D., Little, S.E., Lorentzen, L., Shields, J., Sullivan, M.P., Carlin, E.P., 2009. 
Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, 
Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States: results 
of a national clinic-based serologic survey. Veterinary Parasitology 160(1-2):138-
148. 
Breitschwerdt, E.B., Hegarty, B.C., Hancock, S.I., 1998. Doxycycline hyclate treatment 
of experimental canine ehrlichiosis followed by challenge inoculation with two 
Ehrlichia canis strains. Antimicrobial Agents and Chemotherapy 42(2):362-368. 
Centers for Disease Control and Prevention, 2014. Avoiding Ticks. Updated May 5, 
2014. Available at http:/www.cdc.gov/Ticks/avoid/index.html, accessed Mar 10, 
2015. 
Cisak, E., Wojcik-Fatla, A., Zajac, V., Dutkiewicz, J., 2012. Repellents and acaricides as 
personal protection measures in the prevention of tick-borne diseases. Annals of 
Agricultural and Environmental Medicine 19(4):625-630. 
134 
 
Crocquet-Valdes, P.A., Thirumalapura, N.R., Ismail, N., Yu, X., Saito, T.B., Stevenson, 
H.L., Pietzsch, C.A., Thomas, S., Walker, D.H., 2011. Immunization with Ehrlichia 
p28 outer membrane protein confers protection in a mouse model of ehrlichiosis. 
Clinical and Vaccine Immunology 18(12):2018-2025. 
Dawson, J.E., Biggie, K.L., Warner, C.K., Cookson, K., Jenkins, S., Levine, J.F., Olson, 
J.G., 1996. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic 
agent of human ehrlichiosis, in dogs from southeast Virginia. American Journal of 
Veterinary Research 57(8):1175-1179. 
Domingos A., Antunes, S., Borges, L., Rosario, V.E., 2013. Approaches towards tick and 
tick-borne disease control. Revista da Sociedade Brasileira de Medicina Tropical 
46(3):265-269. 
Estrada-Peña, A., de la Fuente, J., 2014. The ecology of ticks and epidemiology of tick-
borne viral diseases. Antiviral Research 108:104-128. 
Keirans, J.E., Litwak, T.R., 1989. Pictoral key to the adults of hard ticks, family Ixodidae 
(Ixodida: Ixodoidea), east of the Mississippi River. Journal of Medical Entomology 
26(5):435-448.  
Kordick, S.K., Breitschwerdt, E.B., Hegarty, B.C., Southwick, K.L., Colitz, C.M., 
Hancock, S.I., Bradley, J.M., Rumbough, R., McPherson, J.T., MacCormack, J.N., 
1999. Coinfection with multiple tick-borne pathogens in a Walker Hound kennel in 
North Carolina. Journal of Clinical Microbiology 37(8):2631-2638. 
Liddell, A.M., Stockham, S.L., Scott, M.A., Sumner, J.W., Paddock, C.D., Gaudreault-
Keener, M., Arens, M.Q., Storch, G.A., 2003. Predominance of Ehrlichia ewingii in 
Missouri dogs. Journal of Clinical Microbiology 41(10):4617-4622. 
135 
 
Little, S.E., Hostetler, J., Kocan, K.M., 2007. Movement of Rhipicephalus sanguineus 
adults between co-housed dogs during active feeding. Veterinary Parasitology 150(1-
2):130-145. 
Little, S.E., O’Connor, T.P., Hempstead, J., Saucier, J., Reichard, M.V., Meinkoth, K., 
Meinkoth, J.H., Andrews, B., Ullom, S., Ewing, S.A., Chandrashekar, R., 2010. 
Ehrlichia ewingii infection and exposure rates in dogs from the southcentral United 
States. Veterinary Parasitology 172(3-4):355-360. 
Little, S.E., Beall, M.J., Bowman, D.D., Chandrashekar, R., Stamaris, J., 2014. Canine 
infection with Dirofilaria immitis, Borrelia burgdorferi, Anaplasma spp., and 
Ehrlichia spp., in the United States, 2010-2012. Parasites & Vectors 7:257. 
Loftis, A.D., Mixson, T.R., Stromdahl, E.Y., Yabsley, M.J., Garrison, L.E., Williamson, 
P.C., Fitak, R.R., Fuerst, P.A., Kelly, D.J., Blount, K.W., 2008. Geographic 
distribution and genetic diversity of the Ehrlichia sp. from Panola Mountain in 
Amblyomma americanum. BMC Infectious Diseases 8:54. 
Mesonet, 2015. Lake Carl Blackwell Station Monthly Summary. Available at: 
https://www.mesonet.org/index.php/weather/station_monthly_summaries Accessed 
Mar 13, 2015. 
McQuiston, J.H., Paddock, C.D., Holman, R.C., Childs, J.E., 1999. The human 
ehrlichioses in the United States. Emerging Infectious Diseases 5(5):635-642. 
Murphy, G.L., Ewing, S.A., Whitworth, L.C., Fox, J.C., Kocan, A.A., 1998. A molecular 
and serologic survey of Ehrlichia canis, E. chaffeensis, and E. ewingii in dogs and 
ticks from Oklahoma. Veterinary Parasitology 79(4):325-339. 
136 
 
Nicholson, W.L., Allen, K.E., McQuiston, J.H., Breitschwerdt, E.B., Little, S.E., 2010. 
The increasing recognition of rickettsial pathogens in dogs and people. Trends in 
Parasitology 26(4):205-212. 
Parola, P., Raoult, D., 2001. Ticks and tickborne bacterial diseases in humans: an 
emerging infectious threat. Clinical Infectious Diseases 33(5):749. 
Qurollo, B.A., Chandrashekar, R., Hegarty, B.C., Beall, M.J., Stillman, B.A., Liu, J., 
Thatcher, B., Pultorak, E., Cerrito, B., Walsh, M., Breitschwerdt, E.B., 2014. A 
serological survey of tick-borne pathogens in dogs in North America and the 
Caribbean as assessed by Anaplasma phagocytophilum, A. platys, Ehrlichia canis, E. 
chaffeensis, E. ewingii, and Borrelia burgdorferi species-specific peptides. Infection 
Ecology & Epidemiology 4:10.3402/iee.v4.24699. 
Ristic, M., Huxsoll, D.L., Weisiger, R.M., Hildebrandt, P.K., Nyindo, M.B., 1972. 
Serological diagnosis of tropical canine pancytopenia by indirect 
immunofluorescence. Infection and Immunity 6(3):226-231. 
Rudoler, N., Baneth, G., Eyal, O., van Straten, M., Harrus, S., 2012. Evaluation of an 
attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis. 
Vaccine 31(1):226-233. 
Stafford, K.C., 2007. Tick Management Handbook. The Connecticut Agricultural 
Experiment Station Bulletin No. 1010. 
Starkey, L.A., Barrett, A.W., Chandrashekar, R., Stillman, B.A., Tyrrell, P., Thatcher, B., 
Beall, M.J., Gruntmeir, J.M., Meinkoth, J.H., Little, S.E., 2014. Development of 
antibodies to and PCR detection of Ehrlichia spp. in dogs following natural tick 
exposure. Veterinary Microbiology 173(3-4):379-384. 
137 
 
Starkey, L.A., Barrett, A.W., Beall, M.J., Chandrashekar, R., Thatcher, B., Tyrrell, P., 
Little, S.E., 2015. Persistent Ehrlichia ewingii infection in dogs after natural tick 
exposure. Journal of Veterinary Internal Medicine 29:552-555. 
Thomas, S., Thirumalapura, N.R., Crocquet-Valdes, P.A., Luxon, B.A., Walker, D.H., 
2011. Structure-based vaccines provide protection in a mouse model of ehrlichiosis. 
PLOS One 6(11):e27981. 
Yabsley, M.J., Adams, D.S., O’Connor, T.P., Chandrashekar, R., Little, S.E., 2011. 
Experimental primary and secondary infections of domestic dogs with Ehrlichia 
ewingii. Veterinary Microbiology 150(3-4):315-321. 
138 
 
Table 1. Tick infestations on dogs following natural tick re-exposure. 
 
a
























Dog Total number of attached ticks (% of adults)  
 Amblyomma americanum Dermacentor variabilis Nymphs
a
 Total 
2 55 (87.3%) 8 (12.7%) 2 65  
3 58 (93.5%) 4 (6.5%) 8 70  
6 56 (91.8%) 5 (8.2%) 10 71  
7 48 (96.0%) 2 (4.0%) 8 58  
Total 217 (91.9%) 19 (8.1%) 28 264  
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Table 2. Detection of Ehrlichia ewingii by nested (and real-time) PCR in 4 dogs 
following tick re-exposure and IV sub-inoculation. 
 
   a
Rickettsemia detected in 29/36 samples throughout this study period following natural 
tick re-exposure. 
   b
Rickettsemia detected in 15/17 samples throughout this study period following natural 
tick re-exposure. 
  *Day of IV sub-inoculation: sample collected prior to IV sub-inoculation. 
   c
Total number of consecutive days from D170 – D216, inclusive, E. ewingii was 
detected by nested PCR. 
  
Study Day Dog number 
 2 3 6 7 
D–25 – (–) – (–) + (+) – (–) 
D–4 –  – + – 




 – (–) 
D170* –  –  + –  
D174 –  –  + –  
D177 –  –  + –  
D181 –  + + + 
D184 + + + + 
D188 + + + + 
D191 + + + + 
D195 + + + –  
D198 + + + –  
D202 + + + –  
D205 + + + –  
D209 –  + + –  
D212 –  –  + –  
D216 –  –  + –  
Total
c
 21 28 46 10 
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Figure 1. Inverse titers detected by IFA in dogs for four months following tick re-
exposure. 
 





































Figure 2. Inverse titers detected by IFA in dogs for six weeks following IV sub-
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 Vector-borne pathogens, including the tick transmitted bacteria Ehrlichia canis, 
are of concern to people and dogs on some Caribbean islands, including Haiti, where 
survey data for E. canis and other canine vector-borne infections are lacking. To 
determine the prevalence of Ehrlichia spp. infection in dogs from Haiti, we conducted a 
molecular and serologic survey of whole blood collected from 210 owned dogs in 2013, 
28 (13.3%) of which were infested with Rhipicephalus sanguineus ticks at the time of 
blood collection. No other tick species were identified on these dogs. A commercially 
available ELISA (SNAP® 4Dx® Plus) detected antibodies of Ehrlichia spp. in whole 
blood samples from 69/210 (32.9%) dogs, and PCR assays detected 16S rDNA fragments 
of E. canis in 15/207 (7.2%) dogs; none of the 207 canine samples tested were PCR-
positive for E. chaffeensis or E. ewingii. Co-infection of E. canis with Anaplasma spp., 
Dirofilaria immitis, or both was detected by serology in 39/210 (18.6%) dogs. By PCR, 
co-infections with Babesia canis vogeli, D. immitis, or Hepatozoon canis were detected 
in 8/207 (3.9%) dogs: The common nature of E. canis infections along with the presence 
of additional vector-borne pathogens in these dogs, some of which are zoonotic, suggests 
that canine and human health in Haiti would benefit from vector-control programs to 









In dogs, just as in people, tick-borne pathogens are a cause of morbidity and 
mortality. At least five Ehrlichia spp. have been reported from dogs throughout the 
world, all of which are zoonotic: E. canis, E. chaffeensis, E. ewingii, E. muris, and Panola 
Mountain Ehrlichia sp. (Donatien and Lestoquard, 1935; Ewing and Buckner, 1965; 
Maeda et al., 1987; Anderson et al., 1991; Anderson et al., 1992; Dawson and Ewing, 
1992; Dawson et al., 1996; Buller et al., 1999; Perez et al., 2006; Reeves et al., 2008; 
Pritt et al., 2011; Hegarty et al., 2012; Qurollo et al., 2013). Of those Ehrlichia spp., E. 
canis, E. chaffeensis, and E. ewingii have been reported in dogs from areas outside of the 
U.S., but only E. canis has been reported in dogs from Caribbean islands surveyed to date 
(Bool and Sutmoller; 1957; Huxsoll et al., 1970; Ndip et al., 2005; Georges et al., 2008; 
Gutiérrez et al., 2008; Yabsley et al., 2008; Yu et al., 2008; Kelly et al., 2013; Loftis et 
al., 2013; Qurollo et al., 2014). To our knowledge, there are no reports in the literature 
regarding the presence of any tick-borne pathogens in dogs from Haiti. 
Ehrlichia spp. are vectored by a variety of ticks. Rhipicephalus sanguineus, the 
brown dog tick, is primarily responsible for transmission of E. canis, although 
Dermacentor variabilis, the American dog tick, has also been shown to be a competent 
vector (Groves et al., 1975; Johnson et al., 1998). The primary vector of E. chaffeensis 
and E. ewingii is Amblyomma americanum, the lone star tick (Anziani et al., 1990; Ewing 
et al., 1995). Although DNA of E. chaffeensis and E. ewingii has been detected in other 
tick species, namely R. sanguineus and D. variabilis, and R. sanguineus has been shown 
to acquire E. chaffeensis from experimentally infected dogs, transmission by these 
potential vector ticks has not yet been confirmed (Murphy et al., 1998; Steiert and Gilfoy, 
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2002; Ndip et al., 2007; Fritzen et al., 2011; Stoffel et al., 2014).  Rhipicephalus 
sanguineus is reported as the most common tick infesting dogs from the Caribbean 
islands (L’Hostis et al., 1998; Yabsley et al., 2008; Asgarali et al., 2012; Kelly et al., 
2013; Loftis et al., 2013; Crowdis, personal communication).     
Clinical signs associated with Ehrlichia spp. infections in dogs are usually most 
severe if infected with E. canis (Little, 2010). In acute stages of disease, dogs typically 
present with a fever and may be lethargic and anorexic; hemogram analysis may reveal a 
pancytopenia (Wilkins et al., 1967; Huxsoll et al., 1969, 1970; Walker et al., 1970; 
Huxsoll et al., 1972). Dogs may also develop chronic illness which is usually severe, with 
renal, ocular, neurologic, and hematologic complications (Mylonakis et al., 2004; Little, 
2010). Ehrlichia ewingii can also cause disease in dogs, although clinical signs are often 
less severe than those seen during infection with E. canis. Dogs with symptomatic E. 
ewingii infections are usually febrile, thrombocytopenic, and may exhibit polyarthritic 
lameness (Cowell et al., 1988; Anderson et al., 1992; Goodman et al., 2003; Yabsley et 
al., 2011). Canine infection with E. chaffeensis can be associated with mild clinical 
illness although most dogs molecularly diagnosed with E. chaffeensis infection are 
asymptomatic (Little, 2010; Dawson and Ewing 1992; Zhang et al., 2003; Starkey et al., 
2014).   
Canine ehrlichiosis caused by E. canis is commonly diagnosed in dogs from the 
Caribbean, including those presented to veterinary teaching hospitals in the region 
(Yabsley et al., 2008; Kelly et al., 2013; Loftis et al., 2013). Studies of dogs from the 
region report seroprevalences of 24.1% to 47.6% while circulating bacterial DNA has 
been reported from 14.1% to 24.7% of dogs (Georges et al., 2008; Hoff et al., 2008; 
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Yabsley et al., 2008; Asgarali et al., 2012; Kelly et al., 2013, Loftis et al., 2013; Qurollo 
et al., 2014). To date, there have been no reports of human infection with E. canis from 
the Caribbean although R. sanguineus ticks will feed on people and E. canis has been 
detected in human patients from Venezuela (Venzal et al., 2003; Dantas-Torres et al., 
2006; Nicholson et al., 2006; Perez et al., 2006; Otranto et al., 2014; Liyanaarachchi et 
al., 2015).  
Here we report the results of a survey conducted to better understand the 
ehrlichial agents infected and tick species infesting dogs in Haiti. 
 
MATERIALS AND METHODS 
Dogs 
From February to April 2013, blood samples were collected from 210 dogs 
presented to government sponsored vaccination clinics throughout Haiti. Age of each dog 
was provided by the owner. 
Whole Blood Sample Testing  
Whole blood (EDTA) samples (n=210) were tested by a commercial lateral flow 
assay (SNAP® 4Dx® Plus, IDEXX Laboratories, Inc., Westbrook, Maine) designed to 
detect antibodies generated against E. canis and E. ewingii (Stillman et al., 2014).  
Nested PCR was used to evaluate whole blood samples (n=207) for Ehrlichia spp. 
infection as previously described (Little et al, 2010). Briefly, DNA was extracted from 
200 µL of anticoagulated whole blood with a commercial kit (Illustra™ blood genomic 
Prep Mini Spin Kit, GE Healthcare UK Limited, Buckinghamshire, UK) and then used in 
nested PCR assays for 16S rDNA fragments as previously described (Little et al., 2010). 
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Negative water controls were included in each extraction and amplification steps; 
separate, dedicated laboratory spaces were used from the DNA extraction through 
purification for sequencing. All amplicons were purified (Wizard PCR Preps, Promega 
Corporation, Madison, Wisconsin), commercially sequenced (SimpleSeq™, Eurofins 
MWG Operon Inc., Huntsville, Alabama; Molecular Core Facility at Oklahoma State 
University, Stillwater, Oklahoma), and resultant sequences were analyzed using the Basic 
Local Alignment Search Tool (BLAST) and compared with E. canis sequences listed in 
the National Center for Biotechnology Information database.  
Tick Collection and Identification 
Dogs were examined for the presence of ticks; representative ticks were collected 
from infested dogs and placed into 70% ethanol and later identified to species by 
morphological characteristics (Keirans and Litwak, 1989).  
Statistical Analysis 
 Infection with Ehrlichia spp. antibodies and infection with Ehrlichia canis DNA 
were compared to age groups (<2, 2 – 3.9, 4 – 6.9, and 7+ years) using Chi-square tests 
with significance assigned at p < 0.05. Age was also compared to Ehrlichia spp. antibody 
status using a Mann-Whitney rank sum test with significance assigned at p < 0.05. 
 
RESULTS 
Ages of dogs included in this study ranged from 6 months to 13 years (average 
age = 3.8 ± 2.6 years). Commercial ELISA identified Ehrlichia spp. antibodies in 69/210 
(32.9%) dogs (Table 1). Serologic evidence of co-exposure or -infection of E. canis with 
at least one additional vector-borne pathogen was seen in 39/210 (18.6%) dogs, including 
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Anaplasma spp. (13/210; 6.2%), Dirofilaria immitis (16/210; 7.6%), and all 3 agents 
(10/210; 4.8%) (Table 1). Ehrlichia canis DNA was detected in 15/207 (7.2%) dogs; 
evidence of active co-infection with other vector-borne pathogens was identified in 8/207 
(3.9%) of dogs, including Babesia canis vogeli (1/207; 0.5%), Dirofilaria immitis (4/207; 
1.9%), and Hepatozoon canis (3/207; 1.4%) (data not shown). Sequence of all 15 E. canis 
amplicons were identical to one another and 99.7% identical to previously reported E. 
canis sequences from the U.S. (NR_074283), Italy (GQ857078), and Brazil (KJ995842). 
Neither E. chaffeensis nor E. ewingii DNA were detected in any dog.  
Tick infestation was identified on 28/210 (13.3%) dogs. All ticks submitted for 
morphological identification (20 nymphs, 9 male, and 15 female) were morphologically 
identified as Rhipicephalus sanguineus sensu lato. 
 The prevalence of Ehrlichia spp antibodies increased significantly by age 
(χ
2
=12.31; df = 3; p = 0.006), from 12.8% for dogs < 2 years to 31.2%, 39.1%, and 
50.0% for dogs 2 – 3.9 years, 4 – 6.9 years, and 7+ years, respectively. However, 
prevalence of E. canis DNA detected by PCR did not differ by age group (χ
2
=1.63; df = 
3; p = 0.652).  The median age of dogs identified as Ehrlichia spp. antibody positive was 
significantly higher (median age = 4 years) than the median age of dogs without 
Ehrlichia spp. antibodies (median age = 3 years; Z=-3.52; df = 208; p < 0.001).  
 
DISCUSSION 
This study is the first to document Ehrlichia canis infections and Rhipicephalus 
sanguineus infestations in dogs from Haiti. Nearly one-third of dogs tested had detectable 
antibodies to Ehrlichia spp., a prevalence comparable with reports from other islands in 
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the Caribbean which show seroprevalence of Ehrlichia spp. infection ranging between 
24% and 48% of tested dogs (Hoff et al., 2008; Yabsley et al., 2008; Asgarali et al., 2012; 
Kelly et al., 2013, Loftis et al., 2013; Qurollo et al., 2014). The presence of antibodies in 
these dogs does not necessarily indicate an active, current infection; only 15 of the 69 
dogs with antibodies also had detectable DNA of E. canis present in their blood to 
confirm active infection (Baneth et al., 1996; da Costa et al., 2005; Little et al., 2010). It 
is likely that the remaining antibody-positive dogs were chronically infected with low-
level rickettsemia that was below the level of detection for the PCR assay or previously 
infected with antibodies remaining in circulation; Ehrlichia canis DNA was not detected 
in any seronegative dog. The presence of antibody in dogs with E. canis has been 
documented several years after initial infection (Ewing and Buckner, 1965; Bartsch and 
Greene, 1996; Harrus et al., 1998). Our finding of fewer PCR-positive dogs in 
comparison to sero-positive dogs mimics what has been reported in dogs from other 
Caribbean islands (Yabsley et al., 2008; Kelly et al., 2013; Loftis et al., 2013).  
Rhipicephalus sanguineus sensu lato was the only tick identified from any of the 
dogs examined in this study. Data from other studies of tick infestations on dogs from 
other Caribbean islands support our finding that R. sanguineus is the most common, if not 
the sole, species of tick infesting dogs in the region (L’Hostis et al., 1998; Yabsley et al., 
2008; Asgarali et al., 2012; Kelly et al., 2013; Loftis et al., 2013; Crowdis, personal 
communication). Rhipicephalus sanguineus is now known to be a species complex 
comprised of as many as 5 distinct species of ticks (Dantas-Torres et al., 2013), and 
further molecular characterization of the morphotype(s) present in the Caribbean would 
be of interest. Since the discovery of other Ehrlichia spp. DNA in R. sanguineus from 
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other parts of the world, this tick has been implicated as a potential vector for the 
transmission of E. chaffeensis and E. ewingii; however, the present study found no 
molecular evidence of either E. chaffeensis or E. ewingii in any of the dogs from Haiti, 
nor has there been any report of a dog infected with either of these Ehrlichia spp. from 
any other island in the Caribbean (Murphy et al., 1998; Ndip et al., 2007; Yabsley et al., 
2008; Qurollo et al., 2014; Stoffel et al., 2014).  
Routine, consistent use of products that control ticks on dogs and thus may 
prevent the transmission of tick-borne pathogens is lacking throughout Haiti and on other 
Caribbean islands (Kelly et al., 2013; Loftis et al., 2013; Crowdis, personal 
communication). Use in the region is considered further limited by lack of knowledge on 
the part of pet owners about the risks that ticks pose to pets and people; scarcity of 
control products; or prohibitive cost (Crowdis, personal communication). Public and pet 
health may benefit from communicating the health risks associated with ticks to the 
public through routes such as the established government sponsored rabies vaccination 
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Table 1. Seroprevalence of Ehrlichia spp. and other select vector-borne pathogens in 
dogs (n=210) from Haiti. 
Vector-borne infectious agent # dogs positive (%) 
Total Ehrlichia spp. antibodies detected 69/210 (32.9) 
Ehrlichia spp.
b
 alone 30/210 (14.3) 
Co-infections with Ehrlichia spp. 39/210 (18.6) 
Ehrlichia spp.
b
 + Dirofilaria immitis
a
   16/210 (7.6) 
Ehrlichia spp.
b
 + Anaplasma spp.
b
 13/210 (6.2) 
Ehrlichia spp.
b
 + D. immitis
a
 + Anaplasma spp.
b
   10/210 (4.8) 
 
a
Antigen detected by assay 
b











 Tick-borne infections of dogs, particularly those caused by Ehrlichia spp., are 
common in the U.S. and other parts of the world (McQuiston et al., 1999; Parola and 
Raoult, 2001; Ndip et al., 2005; Nicholson et al., 2010; Rani et al., 2011). The two most 
common Ehrlichia spp. infecting dogs from the U.S., E. chaffeensis and E. ewingii, are 
vectored by Amblyomma americanum (Anziani et al., 1990; Long et al., 2003; Bowman 
et al., 2009, Beall et al., 2012; Little et al., 2014; Qurollo et al., 2014). The more 
pathogenic Ehrlichia spp. of dogs, Ehrlichia canis, is less prevalent in dogs from the 
U.S., but is present throughout the world, anywhere that Rhipicephalus sanguineus ticks 
are found (Groves et al., 1975; Yabsley et al., 2008; Bowman et al., 2009, Dantas-Torres, 
2010; Little, 2010; Beall et al., 2012; Kelly et al., 2013; Loftis et al., 2013; Little et al., 
2014; Qurollo et al., 2014). The overarching goals of the research reported in this 
dissertation were to gain a better understanding of the risk of infection with Ehrlichia 
spp. in dogs exposed to ticks in a natural setting, the duration of those infections, and the 
potential for reinfection.  




STUDY 1: CHAPTER III 
 The goal of the first study was to determine the risk of infection with one or more 
Ehrlichia spp. posed to dogs exposed to ticks in a natural setting where A. americanum 
ticks are common. Current survey data of Ehrlichia spp. infections in dogs throughout the 
U.S. demonstrate that dogs in the southcentral and southeastern states, areas where A. 
americanum is the predominant tick, are more commonly infected with Ehrlichia spp. 
when compared to dogs from other regions of the U.S. (Childs and Paddock, 2003; 
Bowman et al., 2009; Beall et al., 2012; Little et al., 2014; Qurollo et al., 2014). 
Following a relatively brief exposure period to various tick habitats in north central 
Oklahoma, all 10 dogs in this study developed infection with E. ewingii; seven dogs 
developed a co-infection with E. chaffeensis as well. Even though infections were 
subclinical in these dogs, both E. chaffeensis and E. ewingii have been reported to cause 
disease in dogs (Cowell et al., 1988; Anderson et al., 1992; Dawson and Ewing, 1992; 
Goodman et al., 2003; Zhang et al., 2003; Yabsley et al., 2011). These data highlight that 
the absence of tick-control allows for infection with potentially pathogenic and zoonotic 
tick-borne agents, and that even brief exposures to ticks can result in infection.  
 
STUDY 2: CHAPTER IV 
 
 The second study sought to determine the length of time a dog could remain 
rickettsemic with E. chaffeensis and E. ewingii following infection that was acquired 
through tick feeding over a known infection period. Reports exist of dogs testing positive 
for Ehrlichia spp. infection by both serologic and molecular methods in the absence of 
any clinical signs, indicating that some of these dogs may be chronically infected (Little 
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et al., 2010; Kelly et al., 2013; Loftis et al., 2013). Infection with E. canis is known to 
persist in some dogs, yet data are lacking regarding long-term infection of E. chaffeensis 
or E. ewingii in dogs following tick feeding (Ewing and Buckner, 1965; Harrus et al., 
1998). Experimental studies looking at the longevity of sole infection in dogs with either 
E. ewingii (intravenous injection) or E. chaffeensis (subcutaneous injection) revealed that 
dogs may remain rickettsemic for at least 144 and 117 days, respectively (Zhang et al., 
2003; Yabsley et al., 2011). Our data regarding longevity of rickettsemia subsequent to 
infection acquired via tick feeding revealed that infection with E. chaffeensis persisted for 
no more than 55 days following initial tick exposure in any dog. Conversely, one dog 
remained rickettsemic with E. ewingii for at least 733 days; an additional two dogs were 
rickettsemic for 460 days each. This is the first report of long-term E. ewingii 
rickettsemia in dogs following infection acquired through tick feeding and contributes to 
the growing body of research that supports the interpretation that dogs may serve as a 
reservoir host of E. ewingii in nature. 
 
STUDY 3: CHAPTER V 
 
 We also sought to evaluate the effect that previous, naturally acquired Ehrlichia 
spp. infections had on the ability of a dog to become reinfected by both tick feeding and 
IV sub-inoculation. Previous work has shown that dogs and mice that were previously 
infected with an Ehrlichia spp. had less severe clinical signs or decreased bacterial loads 
when challenged by reinfection (Breitschwerdt et al., 1998; Crocquet-Valdes et al., 2011; 
Thomas et al., 2011;Yabsley et al., 2011). Our data indicate that reinfection by tick 
feeding did not occur in dogs infected two years prior with Ehrlichia spp. through tick 
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feeding, but infection with E. ewingii via IV sub-inoculation did occur in all three dogs 
challenged. Although this pilot trial lacked necessary components that would allow full 
interpretation of the results, such as naïve dogs during the re-exposure walks and larger 
number of dogs per group, the results suggest that the initial route of infection (i.e. tick 
feeding) may alter the likelihood of reinfection by the same route. Additional 
investigations into this concept are needed.   
 
 
STUDY 4: CHAPTER VI 
 
 The aim of the final study was to determine the identity and prevalence of 
Ehrlichia spp. infections in dogs from Haiti, an island where A. americanum is absent. 
Rhipicephalus sanguineus ticks are the most common ticks reported infesting dogs from 
the Caribbean islands. Furthermore, E. canis, which is vectored by R. sanguineus, is 
commonly detected in dogs from other Caribbean islands (Groves et al., 1975; L’Hostis 
et al., 1998; Georges et al., 2008; Hoff et al., 2008; Yabsley et al., 2008; Asgarali et al., 
2012; Kelly et al., 2013; Loftis et al., 2013; Qurollo et al., 2014; Crowdis, personal 
communication). This study is the first to describe the identity and prevalence of vector-
borne pathogens in dogs from Haiti. Infection with E. canis was detected in 7.2% of dogs 
by PCR and in 32.9% of dogs by serology. The only ticks identified from dogs in this 
study were R. sanguineus, and 13.3% of dogs were actively infested at time of 
examination. Our research along with the work of others indicate that vector-borne 
infections are common in dogs in the Caribbean and that dogs and people on these islands 
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